| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiography, Thoracic | 101 | 2014 | 317 | 12.350 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 84 | 2022 | 458 | 11.840 |
Why?
|
| Radiographic Image Enhancement | 117 | 2014 | 459 | 9.050 |
Why?
|
| Diagnosis, Computer-Assisted | 65 | 2019 | 320 | 9.040 |
Why?
|
| Solitary Pulmonary Nodule | 38 | 2012 | 135 | 6.600 |
Why?
|
| Technology, Radiologic | 51 | 2021 | 102 | 6.120 |
Why?
|
| Apoptosis | 62 | 2013 | 1646 | 5.920 |
Why?
|
| Mammography | 57 | 2013 | 451 | 5.750 |
Why?
|
| Liver | 62 | 2011 | 1191 | 5.700 |
Why?
|
| Encephalomyocarditis virus | 37 | 2016 | 40 | 5.460 |
Why?
|
| Rats | 195 | 2011 | 3921 | 4.760 |
Why?
|
| Subtraction Technique | 33 | 2014 | 133 | 4.750 |
Why?
|
| Pattern Recognition, Automated | 26 | 2013 | 218 | 4.660 |
Why?
|
| ROC Curve | 79 | 2019 | 734 | 4.570 |
Why?
|
| Lung Neoplasms | 59 | 2014 | 2112 | 4.490 |
Why?
|
| Animals | 430 | 2018 | 25594 | 3.970 |
Why?
|
| Tomography, X-Ray Computed | 48 | 2022 | 2439 | 3.970 |
Why?
|
| Cardiovirus Infections | 22 | 2016 | 28 | 3.780 |
Why?
|
| Skin | 29 | 2009 | 538 | 3.600 |
Why?
|
| Brain | 40 | 2019 | 1998 | 3.520 |
Why?
|
| Calcinosis | 32 | 2011 | 232 | 3.470 |
Why?
|
| T-2 Toxin | 16 | 2011 | 18 | 3.380 |
Why?
|
| Image Processing, Computer-Assisted | 43 | 2019 | 1153 | 3.370 |
Why?
|
| Observer Variation | 50 | 2013 | 589 | 3.190 |
Why?
|
| Algorithms | 37 | 2022 | 1768 | 2.990 |
Why?
|
| Image Interpretation, Computer-Assisted | 23 | 2011 | 640 | 2.930 |
Why?
|
| Dog Diseases | 22 | 2008 | 35 | 2.840 |
Why?
|
| Male | 369 | 2019 | 39419 | 2.680 |
Why?
|
| Lung Diseases, Interstitial | 20 | 2011 | 204 | 2.590 |
Why?
|
| Sensitivity and Specificity | 63 | 2012 | 1937 | 2.530 |
Why?
|
| Breast Neoplasms | 40 | 2013 | 2699 | 2.520 |
Why?
|
| Lung | 39 | 2011 | 1067 | 2.400 |
Why?
|
| Lung Diseases | 25 | 2009 | 252 | 2.350 |
Why?
|
| Diagnostic Imaging | 9 | 2016 | 441 | 2.330 |
Why?
|
| Radiology Information Systems | 12 | 2013 | 78 | 2.320 |
Why?
|
| Female | 291 | 2019 | 42244 | 2.280 |
Why?
|
| Radiography | 42 | 2013 | 804 | 2.220 |
Why?
|
| Aging | 25 | 2004 | 623 | 2.170 |
Why?
|
| Humans | 414 | 2022 | 79512 | 2.140 |
Why?
|
| Mice, Inbred BALB C | 46 | 2008 | 1038 | 2.120 |
Why?
|
| Artificial Intelligence | 14 | 2011 | 215 | 2.110 |
Why?
|
| Rats, Wistar | 46 | 2010 | 292 | 2.100 |
Why?
|
| Immunohistochemistry | 56 | 2012 | 1722 | 2.070 |
Why?
|
| Radiology | 10 | 2015 | 179 | 2.050 |
Why?
|
| Dogs | 45 | 2008 | 694 | 2.030 |
Why?
|
| Fetus | 19 | 2010 | 213 | 2.020 |
Why?
|
| Azacitidine | 10 | 2006 | 120 | 1.990 |
Why?
|
| Mice | 131 | 2011 | 10710 | 1.930 |
Why?
|
| Ethylnitrosourea | 8 | 2005 | 28 | 1.900 |
Why?
|
| RNA, Messenger | 53 | 2006 | 1920 | 1.900 |
Why?
|
| Reproducibility of Results | 42 | 2021 | 2570 | 1.900 |
Why?
|
| Image Enhancement | 10 | 2011 | 548 | 1.900 |
Why?
|
| Diabetes Mellitus, Experimental | 22 | 2004 | 187 | 1.860 |
Why?
|
| Bone and Bones | 17 | 2019 | 254 | 1.830 |
Why?
|
| Ultraviolet Rays | 12 | 2004 | 190 | 1.810 |
Why?
|
| Hypotrichosis | 11 | 2003 | 11 | 1.800 |
Why?
|
| Placenta | 16 | 2008 | 172 | 1.780 |
Why?
|
| Breast Diseases | 15 | 2009 | 96 | 1.730 |
Why?
|
| Rats, Inbred F344 | 26 | 2006 | 158 | 1.720 |
Why?
|
| Journal Impact Factor | 2 | 2021 | 16 | 1.690 |
Why?
|
| Cytochrome P-450 Enzyme System | 9 | 2006 | 78 | 1.690 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 35 | 2016 | 869 | 1.670 |
Why?
|
| Tumor Suppressor Protein p53 | 14 | 2010 | 359 | 1.660 |
Why?
|
| Alkylating Agents | 6 | 2011 | 31 | 1.630 |
Why?
|
| Microscopy, Electron | 51 | 2012 | 518 | 1.620 |
Why?
|
| Pregnancy | 50 | 2013 | 2670 | 1.610 |
Why?
|
| Imaging, Three-Dimensional | 12 | 2012 | 556 | 1.600 |
Why?
|
| Myocardium | 24 | 2021 | 520 | 1.460 |
Why?
|
| Rodent Diseases | 17 | 2004 | 38 | 1.380 |
Why?
|
| Magnetic Resonance Imaging | 13 | 2021 | 3069 | 1.370 |
Why?
|
| In Situ Nick-End Labeling | 22 | 2007 | 121 | 1.350 |
Why?
|
| Research | 4 | 2019 | 249 | 1.350 |
Why?
|
| Hepatocytes | 10 | 2005 | 118 | 1.340 |
Why?
|
| Tomography, Spiral Computed | 6 | 2005 | 74 | 1.340 |
Why?
|
| Streptozocin | 12 | 2005 | 53 | 1.340 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 6 | 2008 | 158 | 1.320 |
Why?
|
| Angiography | 20 | 2014 | 200 | 1.310 |
Why?
|
| Thymus Gland | 11 | 2006 | 214 | 1.290 |
Why?
|
| Enterovirus Infections | 13 | 1993 | 40 | 1.280 |
Why?
|
| Liver Neoplasms | 13 | 2010 | 620 | 1.280 |
Why?
|
| Health Physics | 5 | 2019 | 18 | 1.270 |
Why?
|
| Patient Identification Systems | 4 | 2013 | 7 | 1.260 |
Why?
|
| Cat Diseases | 9 | 2011 | 20 | 1.250 |
Why?
|
| Diagnosis, Differential | 31 | 2013 | 1490 | 1.250 |
Why?
|
| Cell Cycle | 10 | 2010 | 498 | 1.250 |
Why?
|
| Organ Size | 32 | 2008 | 353 | 1.240 |
Why?
|
| Gene Expression | 22 | 2016 | 1278 | 1.240 |
Why?
|
| False Positive Reactions | 38 | 2009 | 217 | 1.240 |
Why?
|
| Mice, Inbred ICR | 25 | 2010 | 68 | 1.240 |
Why?
|
| Time Factors | 55 | 2016 | 5143 | 1.230 |
Why?
|
| DNA Fragmentation | 20 | 2006 | 67 | 1.230 |
Why?
|
| Disease Models, Animal | 36 | 2010 | 2173 | 1.200 |
Why?
|
| Neurons | 18 | 2010 | 1471 | 1.190 |
Why?
|
| Swine | 17 | 2018 | 539 | 1.180 |
Why?
|
| Hypertriglyceridemia | 7 | 2009 | 63 | 1.180 |
Why?
|
| Whole Body Imaging | 4 | 2011 | 39 | 1.180 |
Why?
|
| Intracranial Aneurysm | 5 | 2008 | 155 | 1.180 |
Why?
|
| Rats, Sprague-Dawley | 40 | 2008 | 1190 | 1.160 |
Why?
|
| Acetaminophen | 6 | 2009 | 53 | 1.160 |
Why?
|
| Swine Diseases | 6 | 2018 | 14 | 1.150 |
Why?
|
| Pregnancy, Animal | 5 | 2006 | 55 | 1.150 |
Why?
|
| Oxides | 3 | 2010 | 43 | 1.140 |
Why?
|
| Ferric Compounds | 3 | 2010 | 36 | 1.130 |
Why?
|
| Intestine, Small | 7 | 2002 | 290 | 1.130 |
Why?
|
| Kidney | 17 | 2008 | 1169 | 1.100 |
Why?
|
| Mycotoxins | 5 | 2011 | 5 | 1.090 |
Why?
|
| Iron | 3 | 2010 | 152 | 1.090 |
Why?
|
| Lymphoid Tissue | 9 | 2005 | 58 | 1.090 |
Why?
|
| Hydroxyurea | 4 | 2005 | 229 | 1.080 |
Why?
|
| Gene Expression Profiling | 8 | 2009 | 1322 | 1.080 |
Why?
|
| Radiation Injuries, Experimental | 5 | 2003 | 43 | 1.070 |
Why?
|
| Hair Follicle | 5 | 2009 | 26 | 1.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 10 | 2009 | 679 | 1.050 |
Why?
|
| Genotype | 4 | 2019 | 1776 | 1.050 |
Why?
|
| Plaque, Amyloid | 8 | 2004 | 36 | 1.040 |
Why?
|
| Teratogens | 6 | 2005 | 12 | 1.020 |
Why?
|
| Growth Hormone | 6 | 2009 | 97 | 1.020 |
Why?
|
| Trichothecenes | 6 | 2011 | 6 | 1.010 |
Why?
|
| Kidney Diseases | 8 | 2009 | 407 | 1.010 |
Why?
|
| In Situ Hybridization | 22 | 2005 | 305 | 1.000 |
Why?
|
| User-Computer Interface | 4 | 2015 | 184 | 0.990 |
Why?
|
| Japan | 27 | 2017 | 289 | 0.970 |
Why?
|
| Aged | 73 | 2019 | 17394 | 0.950 |
Why?
|
| Spleen | 17 | 2008 | 436 | 0.950 |
Why?
|
| Antineoplastic Agents, Phytogenic | 6 | 2013 | 284 | 0.940 |
Why?
|
| Stem Cells | 5 | 2006 | 336 | 0.930 |
Why?
|
| Middle Aged | 98 | 2019 | 23948 | 0.930 |
Why?
|
| Species Specificity | 22 | 2008 | 677 | 0.920 |
Why?
|
| Movement | 2 | 2015 | 279 | 0.920 |
Why?
|
| Phantoms, Imaging | 6 | 2021 | 419 | 0.910 |
Why?
|
| Emphysema | 1 | 2022 | 13 | 0.910 |
Why?
|
| Surface Properties | 3 | 2021 | 124 | 0.910 |
Why?
|
| Hair | 6 | 2009 | 54 | 0.910 |
Why?
|
| Etoposide | 5 | 2013 | 191 | 0.890 |
Why?
|
| T-Lymphocyte Subsets | 6 | 2004 | 290 | 0.890 |
Why?
|
| Mesocricetus | 17 | 2010 | 104 | 0.890 |
Why?
|
| Phenobarbital | 4 | 2005 | 35 | 0.880 |
Why?
|
| Skin Diseases | 6 | 2001 | 160 | 0.870 |
Why?
|
| Publishing | 2 | 2021 | 84 | 0.870 |
Why?
|
| Liver Diseases | 6 | 2011 | 224 | 0.870 |
Why?
|
| Epidermis | 11 | 2003 | 97 | 0.860 |
Why?
|
| Aged, 80 and over | 39 | 2019 | 6195 | 0.860 |
Why?
|
| RNA, Viral | 13 | 2016 | 326 | 0.860 |
Why?
|
| Cell Division | 20 | 2010 | 703 | 0.860 |
Why?
|
| X-Ray Intensifying Screens | 18 | 2006 | 32 | 0.850 |
Why?
|
| Pulmonary Fibrosis | 8 | 2004 | 101 | 0.840 |
Why?
|
| Lectins | 9 | 1999 | 82 | 0.840 |
Why?
|
| Pregnenolone Carbonitrile | 3 | 2005 | 3 | 0.840 |
Why?
|
| Database Management Systems | 3 | 2013 | 42 | 0.830 |
Why?
|
| Orchitis | 6 | 2010 | 10 | 0.830 |
Why?
|
| Embryonic and Fetal Development | 6 | 2004 | 72 | 0.830 |
Why?
|
| Parathyroid Hormone-Related Protein | 3 | 2005 | 10 | 0.830 |
Why?
|
| Theophylline | 3 | 2006 | 37 | 0.820 |
Why?
|
| Parotid Gland | 6 | 2016 | 32 | 0.820 |
Why?
|
| Gene Expression Regulation, Developmental | 9 | 2013 | 610 | 0.820 |
Why?
|
| Mice, Inbred DBA | 21 | 2016 | 142 | 0.820 |
Why?
|
| Proliferating Cell Nuclear Antigen | 12 | 2003 | 64 | 0.820 |
Why?
|
| Fructose | 5 | 1997 | 34 | 0.810 |
Why?
|
| Clinical Competence | 9 | 2011 | 700 | 0.810 |
Why?
|
| Oxidative Stress | 7 | 2011 | 401 | 0.800 |
Why?
|
| Democracy | 1 | 2020 | 4 | 0.800 |
Why?
|
| Bone Neoplasms | 8 | 2011 | 318 | 0.790 |
Why?
|
| Nitrofurazone | 3 | 2005 | 3 | 0.780 |
Why?
|
| Kidney Glomerulus | 11 | 1997 | 116 | 0.780 |
Why?
|
| Telencephalon | 7 | 2010 | 31 | 0.780 |
Why?
|
| Liver Cirrhosis | 5 | 2010 | 269 | 0.770 |
Why?
|
| Anti-Infective Agents, Local | 3 | 2005 | 20 | 0.770 |
Why?
|
| Keratinocytes | 11 | 2006 | 134 | 0.770 |
Why?
|
| Blood Glucose | 40 | 2008 | 850 | 0.770 |
Why?
|
| Prenatal Exposure Delayed Effects | 3 | 2005 | 149 | 0.760 |
Why?
|
| Radiation Dosage | 17 | 2022 | 222 | 0.760 |
Why?
|
| Antibiotics, Antineoplastic | 3 | 2005 | 108 | 0.760 |
Why?
|
| Neurotoxins | 2 | 2011 | 50 | 0.750 |
Why?
|
| Trophoblasts | 5 | 2008 | 32 | 0.750 |
Why?
|
| Galactosamine | 5 | 2003 | 8 | 0.740 |
Why?
|
| Transforming Growth Factor beta | 7 | 2003 | 273 | 0.740 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2019 | 24 | 0.740 |
Why?
|
| Anniversaries and Special Events | 1 | 2019 | 15 | 0.730 |
Why?
|
| Administration, Oral | 18 | 2005 | 686 | 0.730 |
Why?
|
| Picryl Chloride | 3 | 2004 | 3 | 0.730 |
Why?
|
| Cats | 19 | 2011 | 297 | 0.730 |
Why?
|
| Recombinant Proteins | 13 | 2015 | 1015 | 0.730 |
Why?
|
| Skin Pigmentation | 5 | 2004 | 38 | 0.720 |
Why?
|
| Enzyme Induction | 5 | 2005 | 91 | 0.720 |
Why?
|
| Body Weight | 30 | 2008 | 457 | 0.720 |
Why?
|
| Arteritis | 4 | 2002 | 8 | 0.700 |
Why?
|
| Fibroblast Growth Factor 2 | 5 | 2009 | 56 | 0.700 |
Why?
|
| Research Subjects | 1 | 2019 | 72 | 0.700 |
Why?
|
| Lymphocyte Subsets | 4 | 2002 | 66 | 0.690 |
Why?
|
| Databases as Topic | 6 | 2007 | 89 | 0.690 |
Why?
|
| Adult | 82 | 2019 | 24525 | 0.680 |
Why?
|
| Peyer's Patches | 3 | 2002 | 19 | 0.680 |
Why?
|
| Carcinoma, Hepatocellular | 8 | 2008 | 323 | 0.680 |
Why?
|
| Task Performance and Analysis | 4 | 2008 | 87 | 0.680 |
Why?
|
| Carcinogens | 3 | 2005 | 106 | 0.680 |
Why?
|
| Macrophages | 11 | 2004 | 529 | 0.670 |
Why?
|
| Amyloidosis | 3 | 2010 | 80 | 0.670 |
Why?
|
| Rats, Inbred Strains | 21 | 2002 | 314 | 0.670 |
Why?
|
| Cricetinae | 20 | 2010 | 560 | 0.670 |
Why?
|
| Craniopharyngioma | 2 | 2009 | 11 | 0.670 |
Why?
|
| Photons | 1 | 2017 | 39 | 0.660 |
Why?
|
| Specific Pathogen-Free Organisms | 10 | 2005 | 76 | 0.660 |
Why?
|
| Liver Cirrhosis, Experimental | 4 | 2005 | 7 | 0.650 |
Why?
|
| Epithelial Cells | 9 | 2004 | 619 | 0.650 |
Why?
|
| Psychophysics | 2 | 2008 | 76 | 0.650 |
Why?
|
| Muscle, Smooth, Vascular | 13 | 2001 | 238 | 0.640 |
Why?
|
| Lymphocytes | 6 | 2003 | 459 | 0.640 |
Why?
|
| Spinal Fractures | 3 | 2008 | 73 | 0.640 |
Why?
|
| Odontoblasts | 3 | 2005 | 7 | 0.630 |
Why?
|
| Radionuclide Imaging | 7 | 2011 | 217 | 0.630 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 2 | 2010 | 16 | 0.630 |
Why?
|
| History, 20th Century | 6 | 2019 | 303 | 0.630 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-2 | 2 | 2010 | 19 | 0.630 |
Why?
|
| DNA Damage | 7 | 2013 | 348 | 0.620 |
Why?
|
| Artifacts | 4 | 2008 | 237 | 0.620 |
Why?
|
| Insulin Resistance | 13 | 2001 | 366 | 0.620 |
Why?
|
| Cell Nucleus | 10 | 2006 | 571 | 0.620 |
Why?
|
| Research Personnel | 1 | 2017 | 62 | 0.620 |
Why?
|
| Contrast Media | 7 | 2010 | 1008 | 0.620 |
Why?
|
| Adenoma | 4 | 2009 | 232 | 0.620 |
Why?
|
| Liver Regeneration | 3 | 2007 | 31 | 0.610 |
Why?
|
| Incisor | 3 | 2005 | 7 | 0.610 |
Why?
|
| Water | 2 | 2017 | 259 | 0.610 |
Why?
|
| Submandibular Gland | 4 | 2006 | 17 | 0.600 |
Why?
|
| Data Display | 2 | 2006 | 24 | 0.600 |
Why?
|
| Mass Screening | 10 | 2005 | 587 | 0.600 |
Why?
|
| Nasal Mucosa | 3 | 2003 | 183 | 0.600 |
Why?
|
| Pattern Recognition, Visual | 2 | 2008 | 146 | 0.600 |
Why?
|
| Lactation | 2 | 2006 | 48 | 0.600 |
Why?
|
| Flow Cytometry | 13 | 2006 | 682 | 0.600 |
Why?
|
| Genes, p53 | 5 | 2013 | 113 | 0.600 |
Why?
|
| Mast Cells | 9 | 2003 | 90 | 0.590 |
Why?
|
| Diagnostic Errors | 12 | 2009 | 157 | 0.590 |
Why?
|
| Nitric Oxide Synthase | 8 | 2004 | 128 | 0.590 |
Why?
|
| Kidney Tubules | 5 | 2011 | 95 | 0.590 |
Why?
|
| Cytarabine | 3 | 2007 | 211 | 0.590 |
Why?
|
| Hemofiltration | 1 | 2015 | 10 | 0.580 |
Why?
|
| Dentistry | 1 | 2015 | 5 | 0.580 |
Why?
|
| Electrical Equipment and Supplies | 1 | 2015 | 4 | 0.580 |
Why?
|
| Congresses as Topic | 1 | 2016 | 117 | 0.580 |
Why?
|
| Phosphodiesterase Inhibitors | 2 | 2006 | 37 | 0.580 |
Why?
|
| Antimetabolites, Antineoplastic | 4 | 2007 | 234 | 0.570 |
Why?
|
| DNA Primers | 16 | 2005 | 542 | 0.570 |
Why?
|
| Ultrasonography | 6 | 2012 | 648 | 0.560 |
Why?
|
| Mice, SCID | 5 | 1998 | 233 | 0.560 |
Why?
|
| Central Nervous System | 4 | 2002 | 144 | 0.560 |
Why?
|
| Amyloid beta-Peptides | 6 | 2008 | 158 | 0.560 |
Why?
|
| Hepatectomy | 5 | 2007 | 148 | 0.560 |
Why?
|
| Rats, Inbred BN | 9 | 2005 | 37 | 0.560 |
Why?
|
| Mice, Inbred Strains | 15 | 2008 | 310 | 0.550 |
Why?
|
| Electroencephalography | 1 | 2019 | 669 | 0.550 |
Why?
|
| Isoenzymes | 7 | 2005 | 269 | 0.550 |
Why?
|
| Bile Ducts | 6 | 2000 | 57 | 0.550 |
Why?
|
| Ribs | 8 | 2006 | 45 | 0.540 |
Why?
|
| Cervical Vertebrae | 2 | 2008 | 81 | 0.540 |
Why?
|
| Bleomycin | 3 | 2003 | 94 | 0.540 |
Why?
|
| Endothelium, Vascular | 13 | 2002 | 428 | 0.540 |
Why?
|
| Blood Vessel Prosthesis | 5 | 1997 | 217 | 0.540 |
Why?
|
| Cell Movement | 4 | 2006 | 733 | 0.540 |
Why?
|
| Abnormalities, Drug-Induced | 3 | 2004 | 20 | 0.540 |
Why?
|
| Acetylcysteine | 3 | 2005 | 67 | 0.540 |
Why?
|
| Polymerase Chain Reaction | 14 | 2007 | 921 | 0.530 |
Why?
|
| Magnetic Resonance Angiography | 3 | 2006 | 248 | 0.530 |
Why?
|
| Chemokines | 2 | 2005 | 72 | 0.520 |
Why?
|
| Lacrimal Apparatus | 3 | 2016 | 10 | 0.520 |
Why?
|
| Cerebral Amyloid Angiopathy | 3 | 1999 | 7 | 0.520 |
Why?
|
| Analgesics, Non-Narcotic | 2 | 2009 | 46 | 0.520 |
Why?
|
| Brain Injuries | 2 | 2006 | 140 | 0.510 |
Why?
|
| Databases, Factual | 12 | 2008 | 756 | 0.510 |
Why?
|
| Monitoring, Physiologic | 1 | 2015 | 266 | 0.510 |
Why?
|
| Triglycerides | 14 | 2008 | 232 | 0.510 |
Why?
|
| Mice, Inbred C57BL | 22 | 2008 | 3052 | 0.510 |
Why?
|
| Professional Role | 1 | 2014 | 41 | 0.510 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 2 | 2011 | 16 | 0.500 |
Why?
|
| Deafness | 13 | 2006 | 46 | 0.500 |
Why?
|
| Osteoporosis | 4 | 2019 | 119 | 0.500 |
Why?
|
| Histocytochemistry | 14 | 1998 | 129 | 0.500 |
Why?
|
| Nephritis, Interstitial | 2 | 2003 | 47 | 0.500 |
Why?
|
| Rats, Nude | 8 | 2005 | 22 | 0.500 |
Why?
|
| Bromodeoxyuridine | 8 | 2010 | 59 | 0.490 |
Why?
|
| Interdisciplinary Communication | 1 | 2014 | 123 | 0.490 |
Why?
|
| Femur | 6 | 2019 | 105 | 0.480 |
Why?
|
| Software | 10 | 2009 | 633 | 0.480 |
Why?
|
| Computer Terminals | 2 | 2010 | 7 | 0.480 |
Why?
|
| Operating Rooms | 1 | 2014 | 118 | 0.480 |
Why?
|
| Embryo, Mammalian | 6 | 2006 | 201 | 0.480 |
Why?
|
| Expert Systems | 3 | 2009 | 18 | 0.480 |
Why?
|
| Circoviridae Infections | 2 | 2002 | 3 | 0.470 |
Why?
|
| Circovirus | 2 | 2002 | 5 | 0.470 |
Why?
|
| Injections, Intraperitoneal | 11 | 2013 | 101 | 0.470 |
Why?
|
| Sunburn | 3 | 2003 | 7 | 0.470 |
Why?
|
| Thymus Neoplasms | 2 | 2004 | 37 | 0.470 |
Why?
|
| Immunoenzyme Techniques | 13 | 2002 | 301 | 0.470 |
Why?
|
| Collagen | 8 | 2001 | 262 | 0.470 |
Why?
|
| Sulfanilamides | 3 | 2002 | 5 | 0.470 |
Why?
|
| B-Lymphocyte Subsets | 2 | 2003 | 43 | 0.470 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 2 | 2003 | 38 | 0.470 |
Why?
|
| Lymph Nodes | 7 | 2004 | 507 | 0.460 |
Why?
|
| Nuclear Medicine | 1 | 2012 | 6 | 0.460 |
Why?
|
| Cells, Cultured | 23 | 2005 | 2787 | 0.460 |
Why?
|
| Enzyme Inhibitors | 7 | 2006 | 626 | 0.460 |
Why?
|
| Fenoldopam | 2 | 2002 | 11 | 0.460 |
Why?
|
| Liver Function Tests | 2 | 2011 | 94 | 0.460 |
Why?
|
| Arteriosclerosis | 11 | 2001 | 158 | 0.460 |
Why?
|
| Dermatitis, Allergic Contact | 2 | 2003 | 7 | 0.460 |
Why?
|
| Sialadenitis | 4 | 2010 | 8 | 0.460 |
Why?
|
| Renal Dialysis | 2 | 2015 | 362 | 0.450 |
Why?
|
| Diabetes Mellitus, Type 2 | 14 | 2007 | 1257 | 0.450 |
Why?
|
| Calcium | 8 | 2005 | 1122 | 0.450 |
Why?
|
| Dexamethasone | 3 | 2003 | 305 | 0.450 |
Why?
|
| Antioxidants | 3 | 2003 | 213 | 0.440 |
Why?
|
| Natriuretic Peptide, C-Type | 7 | 2002 | 8 | 0.440 |
Why?
|
| Immunoglobulin G | 6 | 2005 | 442 | 0.440 |
Why?
|
| Fractals | 2 | 2001 | 42 | 0.440 |
Why?
|
| Dermatitis, Contact | 2 | 2004 | 6 | 0.430 |
Why?
|
| Monte Carlo Method | 15 | 2007 | 182 | 0.430 |
Why?
|
| Patient Care Team | 1 | 2014 | 264 | 0.430 |
Why?
|
| Vasodilator Agents | 3 | 2002 | 163 | 0.430 |
Why?
|
| Blotting, Western | 10 | 2007 | 777 | 0.430 |
Why?
|
| Biophysical Phenomena | 16 | 2002 | 118 | 0.430 |
Why?
|
| Cluster Analysis | 7 | 2006 | 350 | 0.430 |
Why?
|
| Neuroepithelial Cells | 3 | 2013 | 4 | 0.430 |
Why?
|
| Mutagens | 1 | 2011 | 31 | 0.430 |
Why?
|
| Radiographic Magnification | 15 | 1983 | 16 | 0.430 |
Why?
|
| Adenocarcinoma | 6 | 2004 | 1111 | 0.430 |
Why?
|
| Hydrogen Peroxide | 4 | 2002 | 152 | 0.420 |
Why?
|
| Brain Chemistry | 7 | 2006 | 113 | 0.420 |
Why?
|
| Neutrophils | 5 | 2003 | 291 | 0.420 |
Why?
|
| Biophysics | 16 | 2002 | 152 | 0.420 |
Why?
|
| Models, Statistical | 9 | 2007 | 570 | 0.420 |
Why?
|
| Insulin | 21 | 2008 | 1126 | 0.420 |
Why?
|
| Hyperplasia | 12 | 2018 | 141 | 0.420 |
Why?
|
| Robotics | 1 | 2014 | 252 | 0.420 |
Why?
|
| Philosophy, Medical | 1 | 2010 | 17 | 0.420 |
Why?
|
| Molecular Sequence Data | 23 | 2007 | 3050 | 0.420 |
Why?
|
| Filing | 2 | 2013 | 3 | 0.410 |
Why?
|
| Myelolipoma | 1 | 2010 | 1 | 0.410 |
Why?
|
| Chordoma | 2 | 2008 | 17 | 0.410 |
Why?
|
| Dose-Response Relationship, Drug | 15 | 2006 | 1969 | 0.410 |
Why?
|
| Ribosomal Proteins | 2 | 2002 | 38 | 0.410 |
Why?
|
| Nitric Oxide | 6 | 2000 | 270 | 0.410 |
Why?
|
| Heart | 13 | 2000 | 498 | 0.410 |
Why?
|
| Neural Stem Cells | 1 | 2011 | 58 | 0.410 |
Why?
|
| Glomerular Mesangium | 4 | 1998 | 23 | 0.410 |
Why?
|
| Arthritis, Experimental | 2 | 2002 | 24 | 0.410 |
Why?
|
| Intestines | 4 | 2000 | 405 | 0.410 |
Why?
|
| Mercuric Chloride | 4 | 2003 | 8 | 0.400 |
Why?
|
| Tibia | 3 | 2008 | 75 | 0.400 |
Why?
|
| Liquid Crystals | 2 | 2009 | 12 | 0.400 |
Why?
|
| Area Under Curve | 6 | 2009 | 334 | 0.400 |
Why?
|
| Biomedical Research | 2 | 2017 | 345 | 0.400 |
Why?
|
| Polyurethanes | 4 | 1997 | 9 | 0.400 |
Why?
|
| Myocarditis | 4 | 2010 | 47 | 0.400 |
Why?
|
| Gadolinium DTPA | 1 | 2011 | 254 | 0.400 |
Why?
|
| Radiotherapy, Intensity-Modulated | 1 | 2012 | 181 | 0.400 |
Why?
|
| Atrial Natriuretic Factor | 5 | 1999 | 39 | 0.400 |
Why?
|
| Cell Count | 9 | 2006 | 191 | 0.390 |
Why?
|
| Positron-Emission Tomography | 3 | 2011 | 270 | 0.390 |
Why?
|
| Fibrosis | 4 | 2003 | 188 | 0.390 |
Why?
|
| Hair Removal | 2 | 2009 | 13 | 0.390 |
Why?
|
| Delivery of Health Care | 1 | 2014 | 326 | 0.390 |
Why?
|
| Spinal Cord Diseases | 2 | 2004 | 30 | 0.390 |
Why?
|
| Models, Theoretical | 20 | 2003 | 477 | 0.380 |
Why?
|
| Testis | 5 | 2004 | 153 | 0.380 |
Why?
|
| Tumor Necrosis Factor-alpha | 8 | 2008 | 677 | 0.380 |
Why?
|
| Granuloma | 2 | 2006 | 62 | 0.380 |
Why?
|
| Transcription, Genetic | 6 | 2002 | 1119 | 0.380 |
Why?
|
| Microscopy, Electron, Transmission | 5 | 2007 | 132 | 0.380 |
Why?
|
| Central Nervous System Cysts | 1 | 2009 | 9 | 0.380 |
Why?
|
| Periodicals as Topic | 2 | 2009 | 160 | 0.370 |
Why?
|
| Base Sequence | 18 | 2007 | 2323 | 0.370 |
Why?
|
| Medical Errors | 1 | 2010 | 109 | 0.370 |
Why?
|
| Cytokines | 5 | 2006 | 742 | 0.370 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2005 | 220 | 0.370 |
Why?
|
| Acute Disease | 11 | 2016 | 802 | 0.370 |
Why?
|
| Silicon Dioxide | 2 | 2007 | 40 | 0.370 |
Why?
|
| Cell Proliferation | 7 | 2009 | 1540 | 0.370 |
Why?
|
| Magnetic Resonance Spectroscopy | 3 | 2019 | 303 | 0.370 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 6 | 2004 | 87 | 0.370 |
Why?
|
| Heart Diseases | 5 | 2002 | 288 | 0.360 |
Why?
|
| Wound Healing | 3 | 2006 | 334 | 0.360 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2003 | 334 | 0.360 |
Why?
|
| Bird Diseases | 2 | 2012 | 7 | 0.360 |
Why?
|
| Pituitary Neoplasms | 1 | 2009 | 64 | 0.360 |
Why?
|
| Plant Lectins | 3 | 1998 | 12 | 0.360 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 3 | 1994 | 33 | 0.360 |
Why?
|
| Evaluation Studies as Topic | 25 | 2000 | 268 | 0.360 |
Why?
|
| alpha-MSH | 1 | 2008 | 4 | 0.360 |
Why?
|
| Spinal Cord Compression | 1 | 2008 | 28 | 0.360 |
Why?
|
| Reference Values | 12 | 2018 | 653 | 0.350 |
Why?
|
| Arthritis | 5 | 1998 | 43 | 0.350 |
Why?
|
| Diabetes Mellitus | 5 | 2010 | 742 | 0.350 |
Why?
|
| Genes, MHC Class II | 2 | 2005 | 32 | 0.350 |
Why?
|
| Edema | 10 | 2003 | 71 | 0.350 |
Why?
|
| Protein Array Analysis | 2 | 2005 | 50 | 0.350 |
Why?
|
| Dacryocystitis | 3 | 2005 | 3 | 0.350 |
Why?
|
| Societies, Scientific | 3 | 2017 | 44 | 0.350 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2004 | 400 | 0.350 |
Why?
|
| Pancreas | 15 | 2004 | 222 | 0.350 |
Why?
|
| Interferon-gamma | 6 | 2004 | 439 | 0.350 |
Why?
|
| Dentin | 2 | 2005 | 6 | 0.350 |
Why?
|
| Amyloid beta-Protein Precursor | 3 | 2004 | 138 | 0.350 |
Why?
|
| Apolipoproteins E | 3 | 2018 | 115 | 0.350 |
Why?
|
| Gene Expression Regulation | 11 | 2009 | 1880 | 0.350 |
Why?
|
| Hypercalcemia | 2 | 2005 | 56 | 0.350 |
Why?
|
| Spinal Neoplasms | 1 | 2008 | 51 | 0.350 |
Why?
|
| Proteins | 9 | 2000 | 751 | 0.340 |
Why?
|
| Stroke | 3 | 2012 | 752 | 0.340 |
Why?
|
| Precancerous Conditions | 2 | 2006 | 189 | 0.340 |
Why?
|
| Cholesterol | 16 | 2008 | 366 | 0.340 |
Why?
|
| Hot Springs | 1 | 2007 | 1 | 0.340 |
Why?
|
| Power Plants | 1 | 2007 | 5 | 0.340 |
Why?
|
| PC12 Cells | 5 | 1999 | 114 | 0.340 |
Why?
|
| Signal Transduction | 5 | 2016 | 3144 | 0.340 |
Why?
|
| Thermus thermophilus | 1 | 2007 | 10 | 0.340 |
Why?
|
| Microscopy, Electron, Scanning | 11 | 2009 | 134 | 0.340 |
Why?
|
| Environmental Microbiology | 1 | 2007 | 22 | 0.340 |
Why?
|
| Peptide Fragments | 2 | 2001 | 455 | 0.340 |
Why?
|
| Alzheimer Disease | 2 | 2018 | 328 | 0.340 |
Why?
|
| Growth Substances | 2 | 2005 | 79 | 0.330 |
Why?
|
| Television | 8 | 1988 | 29 | 0.330 |
Why?
|
| Fatty Liver | 3 | 2007 | 118 | 0.330 |
Why?
|
| Macrophages, Peritoneal | 2 | 1998 | 19 | 0.330 |
Why?
|
| Neovascularization, Physiologic | 4 | 2001 | 130 | 0.330 |
Why?
|
| Ear, External | 2 | 2004 | 29 | 0.330 |
Why?
|
| Intestinal Mucosa | 7 | 2001 | 794 | 0.320 |
Why?
|
| Bone Resorption | 5 | 2008 | 42 | 0.320 |
Why?
|
| Tacrolimus | 3 | 2004 | 375 | 0.320 |
Why?
|
| Carbon Tetrachloride | 4 | 2001 | 7 | 0.320 |
Why?
|
| Kinetics | 10 | 2004 | 1524 | 0.320 |
Why?
|
| Peer Review | 2 | 2017 | 22 | 0.320 |
Why?
|
| 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 1 | 2006 | 7 | 0.320 |
Why?
|
| Biotechnology | 2 | 2006 | 26 | 0.320 |
Why?
|
| Lymphatic Diseases | 1 | 2006 | 34 | 0.320 |
Why?
|
| Extracellular Matrix Proteins | 2 | 1997 | 120 | 0.320 |
Why?
|
| Fatal Outcome | 8 | 2012 | 284 | 0.320 |
Why?
|
| Fractures, Compression | 1 | 2006 | 16 | 0.320 |
Why?
|
| Germ-Free Life | 3 | 2002 | 72 | 0.320 |
Why?
|
| Disease Susceptibility | 7 | 2004 | 181 | 0.320 |
Why?
|
| Drug Therapy, Combination | 8 | 2005 | 902 | 0.310 |
Why?
|
| Workload | 1 | 2008 | 125 | 0.310 |
Why?
|
| Portal Vein | 2 | 2010 | 115 | 0.310 |
Why?
|
| Extracellular Matrix | 2 | 1999 | 224 | 0.310 |
Why?
|
| Animals, Newborn | 10 | 2011 | 520 | 0.310 |
Why?
|
| Streptomyces | 4 | 2000 | 20 | 0.310 |
Why?
|
| Paralysis | 3 | 1995 | 21 | 0.310 |
Why?
|
| Kupffer Cells | 1 | 2006 | 13 | 0.310 |
Why?
|
| Cerebral Ventricles | 1 | 2006 | 74 | 0.310 |
Why?
|
| Spinal Cord | 6 | 1995 | 240 | 0.310 |
Why?
|
| Clofibric Acid | 2 | 1997 | 15 | 0.300 |
Why?
|
| Radiography, Dual-Energy Scanned Projection | 2 | 2011 | 13 | 0.300 |
Why?
|
| Fetal Development | 1 | 2006 | 31 | 0.300 |
Why?
|
| New Zealand | 2 | 2021 | 21 | 0.300 |
Why?
|
| Glucose Tolerance Test | 11 | 2007 | 229 | 0.300 |
Why?
|
| Nervous System Malformations | 1 | 2005 | 42 | 0.300 |
Why?
|
| Pulmonary Alveoli | 3 | 2003 | 78 | 0.290 |
Why?
|
| Nerve Tissue Proteins | 4 | 2006 | 489 | 0.290 |
Why?
|
| Prenatal Injuries | 1 | 2005 | 6 | 0.290 |
Why?
|
| Caspase 3 | 4 | 2006 | 160 | 0.290 |
Why?
|
| Cochlear Implants | 7 | 2001 | 30 | 0.290 |
Why?
|
| United States | 6 | 2017 | 6050 | 0.290 |
Why?
|
| Caspases | 4 | 2006 | 155 | 0.290 |
Why?
|
| Data Interpretation, Statistical | 3 | 2009 | 295 | 0.290 |
Why?
|
| Scattering, Radiation | 13 | 1996 | 113 | 0.290 |
Why?
|
| Digestive System | 3 | 2004 | 43 | 0.290 |
Why?
|
| Zygote | 2 | 1997 | 38 | 0.290 |
Why?
|
| Hippocampus | 7 | 2003 | 414 | 0.290 |
Why?
|
| Breast | 2 | 2007 | 265 | 0.290 |
Why?
|
| Receptor, Parathyroid Hormone, Type 1 | 1 | 2005 | 1 | 0.290 |
Why?
|
| Nerve Net | 2 | 2008 | 371 | 0.290 |
Why?
|
| Immunosuppressive Agents | 5 | 2006 | 978 | 0.280 |
Why?
|
| Parkinson Disease | 1 | 2006 | 121 | 0.280 |
Why?
|
| Information Storage and Retrieval | 5 | 2006 | 119 | 0.280 |
Why?
|
| Odontogenesis | 1 | 2005 | 13 | 0.280 |
Why?
|
| DNA, Viral | 3 | 2002 | 268 | 0.280 |
Why?
|
| Antineoplastic Agents | 4 | 2005 | 2268 | 0.280 |
Why?
|
| Sunlight | 2 | 1995 | 26 | 0.280 |
Why?
|
| Neoplasms, Multiple Primary | 2 | 2004 | 101 | 0.280 |
Why?
|
| Pityriasis Rosea | 1 | 2004 | 2 | 0.280 |
Why?
|
| Oncogene Proteins | 1 | 2005 | 58 | 0.280 |
Why?
|
| Ovalbumin | 1 | 2005 | 109 | 0.280 |
Why?
|
| Sepsis | 1 | 2008 | 264 | 0.270 |
Why?
|
| Immediate-Early Proteins | 1 | 2006 | 167 | 0.270 |
Why?
|
| RNA, Antisense | 2 | 2006 | 16 | 0.270 |
Why?
|
| Lymphocyte Count | 2 | 2002 | 91 | 0.270 |
Why?
|
| Rabbits | 10 | 2010 | 656 | 0.270 |
Why?
|
| Pigmentation Disorders | 1 | 2004 | 13 | 0.270 |
Why?
|
| Leukocyte Count | 5 | 2008 | 215 | 0.270 |
Why?
|
| Models, Biological | 15 | 2006 | 1724 | 0.270 |
Why?
|
| Cerebral Cortex | 4 | 2006 | 550 | 0.270 |
Why?
|
| Luminescent Proteins | 1 | 2015 | 147 | 0.270 |
Why?
|
| Murine hepatitis virus | 4 | 1998 | 5 | 0.270 |
Why?
|
| Thymoma | 1 | 2004 | 26 | 0.270 |
Why?
|
| Bone Diseases | 4 | 2007 | 54 | 0.270 |
Why?
|
| Primate Diseases | 1 | 2004 | 4 | 0.260 |
Why?
|
| Liver Transplantation | 2 | 2006 | 1238 | 0.260 |
Why?
|
| Paraplegia | 1 | 2004 | 16 | 0.260 |
Why?
|
| Rejuvenation | 1 | 2004 | 30 | 0.260 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 3 | 2002 | 124 | 0.260 |
Why?
|
| Models, Structural | 17 | 1995 | 59 | 0.260 |
Why?
|
| Macaca fascicularis | 4 | 2001 | 118 | 0.260 |
Why?
|
| Anticonvulsants | 1 | 2005 | 121 | 0.260 |
Why?
|
| Microsomes, Liver | 2 | 2005 | 50 | 0.260 |
Why?
|
| Heme Oxygenase (Decyclizing) | 2 | 2004 | 40 | 0.260 |
Why?
|
| History, 21st Century | 2 | 2019 | 167 | 0.260 |
Why?
|
| Neurodegenerative Diseases | 1 | 2004 | 29 | 0.260 |
Why?
|
| Brain Neoplasms | 5 | 2005 | 701 | 0.260 |
Why?
|
| Catechin | 1 | 2003 | 16 | 0.260 |
Why?
|
| Pancreatic Diseases | 2 | 1996 | 46 | 0.260 |
Why?
|
| Parathyroid Hormone | 1 | 2005 | 209 | 0.260 |
Why?
|
| Receptors, Chemokine | 1 | 2003 | 31 | 0.260 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2004 | 103 | 0.260 |
Why?
|
| Hypersensitivity | 1 | 2005 | 140 | 0.260 |
Why?
|
| Skin Aging | 1 | 2004 | 39 | 0.250 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2002 | 182 | 0.250 |
Why?
|
| Adenine | 1 | 2004 | 85 | 0.250 |
Why?
|
| N-Methylaspartate | 1 | 2003 | 51 | 0.250 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2003 | 45 | 0.250 |
Why?
|
| Ergocalciferols | 8 | 1997 | 38 | 0.250 |
Why?
|
| Receptors, Cell Surface | 1 | 2005 | 286 | 0.250 |
Why?
|
| Human Body | 1 | 2003 | 6 | 0.250 |
Why?
|
| Thoracic Neoplasms | 1 | 2003 | 59 | 0.250 |
Why?
|
| Calibration | 2 | 2017 | 98 | 0.250 |
Why?
|
| Enzyme Activators | 1 | 2003 | 14 | 0.250 |
Why?
|
| Taxoids | 2 | 2000 | 127 | 0.250 |
Why?
|
| Organogenesis | 1 | 2003 | 41 | 0.250 |
Why?
|
| Temperature | 5 | 2015 | 392 | 0.250 |
Why?
|
| Virus Replication | 7 | 2003 | 313 | 0.250 |
Why?
|
| Dietary Fats | 8 | 2008 | 142 | 0.250 |
Why?
|
| Computers | 12 | 2006 | 105 | 0.250 |
Why?
|
| Serum | 3 | 2010 | 23 | 0.240 |
Why?
|
| Retrospective Studies | 11 | 2019 | 7386 | 0.240 |
Why?
|
| Formaldehyde | 1 | 2003 | 53 | 0.240 |
Why?
|
| Living Donors | 1 | 2006 | 308 | 0.240 |
Why?
|
| Automation | 5 | 2012 | 107 | 0.240 |
Why?
|
| Down-Regulation | 7 | 2007 | 501 | 0.240 |
Why?
|
| Diabetes Mellitus, Type 1 | 5 | 2004 | 535 | 0.240 |
Why?
|
| Brain Diseases | 3 | 2008 | 171 | 0.240 |
Why?
|
| Mitosis | 4 | 2006 | 147 | 0.240 |
Why?
|
| X-Ray Film | 14 | 1995 | 36 | 0.240 |
Why?
|
| Psittaciformes | 1 | 2002 | 2 | 0.240 |
Why?
|
| Carcinoma, Squamous Cell | 5 | 2004 | 1025 | 0.240 |
Why?
|
| Laser Therapy | 1 | 2004 | 140 | 0.240 |
Why?
|
| Cell Transplantation | 2 | 2003 | 45 | 0.240 |
Why?
|
| Wasting Syndrome | 1 | 2002 | 3 | 0.240 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 5 | 2005 | 67 | 0.240 |
Why?
|
| Lymphoma | 1 | 2004 | 256 | 0.240 |
Why?
|
| Serositis | 2 | 2002 | 2 | 0.240 |
Why?
|
| Periarthritis | 1 | 2002 | 1 | 0.240 |
Why?
|
| Adenosine Triphosphate | 2 | 1994 | 303 | 0.240 |
Why?
|
| Diphosphonates | 2 | 2019 | 37 | 0.240 |
Why?
|
| Mice, Nude | 3 | 2001 | 764 | 0.230 |
Why?
|
| Electrophoresis, Agar Gel | 5 | 2002 | 50 | 0.230 |
Why?
|
| Oxygen | 4 | 1998 | 700 | 0.230 |
Why?
|
| Islets of Langerhans | 11 | 2004 | 535 | 0.230 |
Why?
|
| Prospective Studies | 5 | 2019 | 3870 | 0.230 |
Why?
|
| Acclimatization | 11 | 1982 | 69 | 0.230 |
Why?
|
| Germ Cells | 1 | 2002 | 99 | 0.230 |
Why?
|
| Th1 Cells | 1 | 2003 | 162 | 0.230 |
Why?
|
| Spinal Cord Neoplasms | 2 | 2000 | 46 | 0.230 |
Why?
|
| Endotoxins | 1 | 2002 | 36 | 0.230 |
Why?
|
| Nitric Oxide Synthase Type II | 5 | 2004 | 85 | 0.230 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-3 | 1 | 2001 | 4 | 0.230 |
Why?
|
| Immunoglobulin E | 4 | 2004 | 142 | 0.230 |
Why?
|
| Physics | 3 | 2021 | 21 | 0.230 |
Why?
|
| Geese | 2 | 2012 | 7 | 0.230 |
Why?
|
| T-Lymphocytes | 3 | 1999 | 1193 | 0.230 |
Why?
|
| Cerebellar Neoplasms | 1 | 2002 | 35 | 0.230 |
Why?
|
| Monkey Diseases | 2 | 2005 | 10 | 0.230 |
Why?
|
| Th2 Cells | 1 | 2003 | 148 | 0.230 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2002 | 101 | 0.230 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2005 | 402 | 0.230 |
Why?
|
| Paclitaxel | 2 | 2000 | 442 | 0.220 |
Why?
|
| Meningeal Neoplasms | 1 | 2002 | 53 | 0.220 |
Why?
|
| Common Bile Duct | 2 | 2000 | 17 | 0.220 |
Why?
|
| Sequence Analysis, DNA | 4 | 2000 | 827 | 0.220 |
Why?
|
| Aorta | 7 | 1996 | 291 | 0.220 |
Why?
|
| Meningioma | 1 | 2002 | 52 | 0.220 |
Why?
|
| Research Design | 2 | 2019 | 559 | 0.220 |
Why?
|
| DNA | 7 | 2006 | 1246 | 0.220 |
Why?
|
| Respiration | 3 | 1994 | 238 | 0.220 |
Why?
|
| Carbon Tetrachloride Poisoning | 1 | 2001 | 3 | 0.220 |
Why?
|
| Administration, Topical | 5 | 2002 | 90 | 0.220 |
Why?
|
| Histological Techniques | 3 | 2007 | 32 | 0.220 |
Why?
|
| Thioacetamide | 1 | 2001 | 1 | 0.220 |
Why?
|
| Hepatitis, Animal | 1 | 2001 | 2 | 0.220 |
Why?
|
| Mathematics | 19 | 1995 | 185 | 0.220 |
Why?
|
| Polynesia | 1 | 2021 | 3 | 0.220 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2001 | 44 | 0.220 |
Why?
|
| Indonesia | 1 | 2021 | 9 | 0.220 |
Why?
|
| Carcinoma, Adenosquamous | 1 | 2001 | 12 | 0.220 |
Why?
|
| Evoked Potentials, Auditory, Brain Stem | 5 | 2001 | 17 | 0.220 |
Why?
|
| Eosinophils | 3 | 2010 | 192 | 0.210 |
Why?
|
| Neuroectodermal Tumors, Primitive | 1 | 2001 | 8 | 0.210 |
Why?
|
| Adenoviridae | 3 | 2002 | 345 | 0.210 |
Why?
|
| Cell Survival | 4 | 2005 | 952 | 0.210 |
Why?
|
| Neurocytoma | 1 | 2000 | 3 | 0.210 |
Why?
|
| Adipose Tissue | 9 | 2010 | 234 | 0.210 |
Why?
|
| Neuropil | 1 | 2000 | 6 | 0.210 |
Why?
|
| Meninges | 1 | 2000 | 12 | 0.210 |
Why?
|
| Gelatin | 5 | 2001 | 24 | 0.210 |
Why?
|
| Frontal Lobe | 1 | 2001 | 120 | 0.210 |
Why?
|
| Rats, Mutant Strains | 4 | 1997 | 23 | 0.210 |
Why?
|
| Bone Marrow | 6 | 2001 | 417 | 0.210 |
Why?
|
| Likelihood Functions | 4 | 2003 | 253 | 0.210 |
Why?
|
| Operations Research | 4 | 1985 | 4 | 0.210 |
Why?
|
| Interleukins | 1 | 2001 | 132 | 0.210 |
Why?
|
| Thoracic Vertebrae | 1 | 2000 | 60 | 0.210 |
Why?
|
| Discriminant Analysis | 4 | 2006 | 64 | 0.200 |
Why?
|
| Neuroglia | 1 | 2000 | 102 | 0.200 |
Why?
|
| Antigens, Viral | 6 | 2003 | 144 | 0.200 |
Why?
|
| Carrier Proteins | 6 | 2000 | 662 | 0.200 |
Why?
|
| Nucleic Acid Hybridization | 2 | 2000 | 245 | 0.200 |
Why?
|
| Bone Regeneration | 3 | 2010 | 51 | 0.200 |
Why?
|
| Common Bile Duct Diseases | 1 | 2000 | 9 | 0.200 |
Why?
|
| Alkaline Phosphatase | 4 | 2009 | 132 | 0.200 |
Why?
|
| Guinea Pigs | 7 | 2010 | 170 | 0.200 |
Why?
|
| Mathematical Computing | 1 | 2000 | 20 | 0.200 |
Why?
|
| Sertoli Cells | 2 | 1997 | 18 | 0.200 |
Why?
|
| Necrosis | 4 | 2005 | 190 | 0.200 |
Why?
|
| Amyloid | 2 | 1997 | 76 | 0.200 |
Why?
|
| Radiopharmaceuticals | 3 | 2011 | 157 | 0.200 |
Why?
|
| Pulmonary Embolism | 1 | 2002 | 199 | 0.200 |
Why?
|
| Tattooing | 1 | 2019 | 6 | 0.200 |
Why?
|
| Cytoplasm | 4 | 2004 | 279 | 0.200 |
Why?
|
| X-Rays | 7 | 2010 | 125 | 0.200 |
Why?
|
| Lasers, Solid-State | 1 | 2019 | 6 | 0.200 |
Why?
|
| Forms and Records Control | 2 | 2013 | 16 | 0.200 |
Why?
|
| Mice, Mutant Strains | 3 | 2006 | 232 | 0.200 |
Why?
|
| Drug Synergism | 4 | 2003 | 304 | 0.200 |
Why?
|
| Mucins | 3 | 1996 | 40 | 0.200 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2001 | 125 | 0.200 |
Why?
|
| Injections, Subcutaneous | 5 | 2003 | 116 | 0.200 |
Why?
|
| Telomerase | 1 | 2000 | 52 | 0.200 |
Why?
|
| Radiometry | 3 | 2017 | 50 | 0.190 |
Why?
|
| Polyphosphates | 2 | 2010 | 8 | 0.190 |
Why?
|
| Hand | 6 | 2015 | 120 | 0.190 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 1999 | 25 | 0.190 |
Why?
|
| Politics | 1 | 2020 | 46 | 0.190 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2000 | 53 | 0.190 |
Why?
|
| Antimetabolites | 3 | 2006 | 23 | 0.190 |
Why?
|
| Spinal Nerve Roots | 2 | 2018 | 17 | 0.190 |
Why?
|
| Immunoglobulin A | 1 | 2000 | 82 | 0.190 |
Why?
|
| Conjugation, Genetic | 2 | 1998 | 21 | 0.190 |
Why?
|
| Hydroquinones | 2 | 1998 | 8 | 0.190 |
Why?
|
| Thumb | 1 | 2019 | 21 | 0.190 |
Why?
|
| Viremia | 2 | 2005 | 49 | 0.190 |
Why?
|
| Mammary Glands, Animal | 1 | 2000 | 78 | 0.190 |
Why?
|
| Hepatitis, Viral, Animal | 2 | 1997 | 2 | 0.190 |
Why?
|
| Oxygenases | 1 | 1999 | 13 | 0.190 |
Why?
|
| Hypertension | 9 | 2000 | 1185 | 0.190 |
Why?
|
| Smoking | 1 | 2003 | 549 | 0.190 |
Why?
|
| Colon | 5 | 1999 | 487 | 0.190 |
Why?
|
| Receptors, Glutamate | 2 | 2000 | 25 | 0.190 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 1999 | 36 | 0.190 |
Why?
|
| Follow-Up Studies | 7 | 2006 | 3553 | 0.190 |
Why?
|
| Heparin | 2 | 1997 | 165 | 0.190 |
Why?
|
| Mucinosis, Follicular | 1 | 1999 | 2 | 0.190 |
Why?
|
| Cochlear Implantation | 4 | 2006 | 30 | 0.190 |
Why?
|
| Glomerulonephritis | 2 | 1996 | 71 | 0.190 |
Why?
|
| Epidermal Growth Factor | 2 | 2001 | 119 | 0.190 |
Why?
|
| Lipid Metabolism | 6 | 2008 | 190 | 0.190 |
Why?
|
| Glycoconjugates | 1 | 1999 | 10 | 0.190 |
Why?
|
| Cell Cycle Proteins | 3 | 2010 | 373 | 0.190 |
Why?
|
| Age Factors | 9 | 2008 | 1797 | 0.190 |
Why?
|
| Melanosis | 1 | 1998 | 3 | 0.180 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2004 | 514 | 0.180 |
Why?
|
| Amino Acid Sequence | 16 | 2004 | 2077 | 0.180 |
Why?
|
| Keratolytic Agents | 1 | 1998 | 4 | 0.180 |
Why?
|
| Blood Proteins | 2 | 1997 | 142 | 0.180 |
Why?
|
| Hematopoietic System | 1 | 1998 | 13 | 0.180 |
Why?
|
| Transgenes | 1 | 1999 | 180 | 0.180 |
Why?
|
| Actinomycetales | 1 | 1998 | 5 | 0.180 |
Why?
|
| Venous Thrombosis | 1 | 2001 | 227 | 0.180 |
Why?
|
| Acid Phosphatase | 1 | 1998 | 34 | 0.180 |
Why?
|
| Sigma Factor | 1 | 1998 | 23 | 0.180 |
Why?
|
| Mitochondrial Proteins | 5 | 2000 | 119 | 0.180 |
Why?
|
| Agrochemicals | 1 | 1998 | 2 | 0.180 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 1998 | 36 | 0.180 |
Why?
|
| Osteoclasts | 1 | 1998 | 33 | 0.180 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 4 | 2006 | 121 | 0.180 |
Why?
|
| Lymphocyte Transfusion | 1 | 1998 | 41 | 0.180 |
Why?
|
| Graft Enhancement, Immunologic | 1 | 1998 | 13 | 0.180 |
Why?
|
| Cold Temperature | 13 | 1987 | 153 | 0.180 |
Why?
|
| Pesticides | 1 | 1998 | 26 | 0.180 |
Why?
|
| Pheochromocytoma | 2 | 2018 | 47 | 0.170 |
Why?
|
| Esophageal Neoplasms | 1 | 2001 | 302 | 0.170 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2019 | 152 | 0.170 |
Why?
|
| Pulmonary Edema | 1 | 1998 | 51 | 0.170 |
Why?
|
| Vestibular Nerve | 2 | 1995 | 30 | 0.170 |
Why?
|
| Coronavirus Infections | 3 | 1998 | 283 | 0.170 |
Why?
|
| Aorta, Thoracic | 5 | 2002 | 163 | 0.170 |
Why?
|
| Indomethacin | 1 | 1998 | 60 | 0.170 |
Why?
|
| Adrenal Medulla | 1 | 2018 | 46 | 0.170 |
Why?
|
| Adrenal Glands | 5 | 2005 | 76 | 0.170 |
Why?
|
| Hypochlorous Acid | 2 | 1995 | 5 | 0.170 |
Why?
|
| Growth Inhibitors | 1 | 1997 | 42 | 0.170 |
Why?
|
| Cell Death | 3 | 2006 | 253 | 0.170 |
Why?
|
| Transforming Growth Factor beta1 | 3 | 2003 | 83 | 0.170 |
Why?
|
| Tretinoin | 1 | 1998 | 124 | 0.170 |
Why?
|
| Sarcoma | 1 | 2019 | 201 | 0.170 |
Why?
|
| Transcription Factors | 5 | 2001 | 1464 | 0.170 |
Why?
|
| Statistics, Nonparametric | 3 | 2008 | 302 | 0.170 |
Why?
|
| Membrane Transport Proteins | 4 | 2000 | 158 | 0.170 |
Why?
|
| Radiotherapy, High-Energy | 1 | 2017 | 49 | 0.170 |
Why?
|
| G1 Phase | 1 | 1997 | 62 | 0.170 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2018 | 57 | 0.170 |
Why?
|
| Fetal Weight | 3 | 2003 | 18 | 0.170 |
Why?
|
| Cyclophosphamide | 2 | 2006 | 280 | 0.170 |
Why?
|
| Technetium Tc 99m Medronate | 2 | 2011 | 10 | 0.170 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2018 | 78 | 0.170 |
Why?
|
| Animals, Genetically Modified | 3 | 2005 | 180 | 0.170 |
Why?
|
| Meningoencephalitis | 1 | 1997 | 7 | 0.170 |
Why?
|
| Culture Techniques | 3 | 2003 | 92 | 0.170 |
Why?
|
| Macrophage Activation | 1 | 1997 | 42 | 0.170 |
Why?
|
| Forecasting | 3 | 2007 | 302 | 0.160 |
Why?
|
| Birds | 1 | 1999 | 133 | 0.160 |
Why?
|
| DNA Replication | 3 | 2005 | 164 | 0.160 |
Why?
|
| DNA Methylation | 2 | 1999 | 568 | 0.160 |
Why?
|
| Case-Control Studies | 5 | 2006 | 1722 | 0.160 |
Why?
|
| Dermis | 3 | 2002 | 26 | 0.160 |
Why?
|
| Gene Transfer Techniques | 1 | 1997 | 148 | 0.160 |
Why?
|
| Gerbillinae | 4 | 2010 | 12 | 0.160 |
Why?
|
| Reperfusion Injury | 1 | 1998 | 133 | 0.160 |
Why?
|
| Myoglobin | 2 | 1998 | 28 | 0.160 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 1999 | 1163 | 0.160 |
Why?
|
| Cell Adhesion Molecules | 1 | 1997 | 160 | 0.160 |
Why?
|
| Clinical Protocols | 1 | 2017 | 154 | 0.160 |
Why?
|
| Feasibility Studies | 1 | 2019 | 720 | 0.160 |
Why?
|
| Plasmids | 5 | 2000 | 282 | 0.160 |
Why?
|
| Awards and Prizes | 1 | 2017 | 31 | 0.160 |
Why?
|
| Circadian Rhythm | 2 | 1999 | 291 | 0.160 |
Why?
|
| Aspartate Aminotransferases | 4 | 2004 | 69 | 0.160 |
Why?
|
| Oocytes | 1 | 1997 | 218 | 0.160 |
Why?
|
| Acne Vulgaris | 1 | 1996 | 31 | 0.160 |
Why?
|
| Receptors, Leptin | 2 | 2007 | 31 | 0.160 |
Why?
|
| Mutation | 6 | 2015 | 3745 | 0.160 |
Why?
|
| Maternal Exposure | 3 | 2010 | 54 | 0.160 |
Why?
|
| Capillaries | 3 | 2003 | 89 | 0.160 |
Why?
|
| Diaphragm | 1 | 1996 | 49 | 0.160 |
Why?
|
| Hernia, Diaphragmatic, Traumatic | 1 | 1996 | 2 | 0.150 |
Why?
|
| Fatty Acids, Nonesterified | 14 | 2008 | 72 | 0.150 |
Why?
|
| Macrophage-1 Antigen | 1 | 1996 | 16 | 0.150 |
Why?
|
| Breeding | 2 | 1994 | 38 | 0.150 |
Why?
|
| Myocardial Reperfusion | 2 | 1993 | 27 | 0.150 |
Why?
|
| Microarray Analysis | 2 | 2006 | 93 | 0.150 |
Why?
|
| Guidelines as Topic | 1 | 2017 | 159 | 0.150 |
Why?
|
| Bone Density | 4 | 2019 | 203 | 0.150 |
Why?
|
| Repressor Proteins | 1 | 2019 | 398 | 0.150 |
Why?
|
| Computational Biology | 1 | 2000 | 515 | 0.150 |
Why?
|
| Early Detection of Cancer | 2 | 2011 | 337 | 0.150 |
Why?
|
| Glucose | 8 | 2000 | 603 | 0.150 |
Why?
|
| Antibodies, Monoclonal | 7 | 2004 | 1367 | 0.150 |
Why?
|
| Cryptorchidism | 1 | 1995 | 12 | 0.150 |
Why?
|
| Drug Interactions | 4 | 2005 | 250 | 0.150 |
Why?
|
| Lens, Crystalline | 1 | 1996 | 65 | 0.150 |
Why?
|
| Societies, Medical | 2 | 2017 | 565 | 0.150 |
Why?
|
| Sequence Homology, Amino Acid | 7 | 2004 | 418 | 0.150 |
Why?
|
| Thyroxine | 8 | 1984 | 318 | 0.150 |
Why?
|
| Phosphoric Diester Hydrolases | 2 | 2006 | 24 | 0.150 |
Why?
|
| Anticholesteremic Agents | 1 | 1997 | 137 | 0.150 |
Why?
|
| Membrane Proteins | 5 | 2005 | 1161 | 0.150 |
Why?
|
| Thermodilution | 1 | 2015 | 20 | 0.150 |
Why?
|
| Nuclear Warfare | 1 | 2015 | 4 | 0.150 |
Why?
|
| Arvicolinae | 1 | 1995 | 3 | 0.150 |
Why?
|
| Up-Regulation | 4 | 2013 | 688 | 0.140 |
Why?
|
| Interferon Type I | 1 | 2016 | 169 | 0.140 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 1998 | 242 | 0.140 |
Why?
|
| Interferons | 1 | 1995 | 123 | 0.140 |
Why?
|
| Coloring Agents | 3 | 2003 | 65 | 0.140 |
Why?
|
| Drug Administration Schedule | 5 | 2001 | 931 | 0.140 |
Why?
|
| L-Lactate Dehydrogenase | 4 | 2002 | 67 | 0.140 |
Why?
|
| Lipidoses | 2 | 1992 | 4 | 0.140 |
Why?
|
| Carbon Dioxide | 3 | 1992 | 186 | 0.140 |
Why?
|
| Ventricular Function, Left | 1 | 1999 | 559 | 0.140 |
Why?
|
| Fibroblasts | 3 | 2003 | 695 | 0.140 |
Why?
|
| Interleukin-10 | 2 | 2008 | 147 | 0.140 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 1997 | 368 | 0.140 |
Why?
|
| Dose-Response Relationship, Immunologic | 2 | 2005 | 43 | 0.140 |
Why?
|
| Accidents, Traffic | 1 | 1996 | 81 | 0.140 |
Why?
|
| Catheter Ablation | 3 | 2001 | 213 | 0.140 |
Why?
|
| Endothelial Growth Factors | 3 | 2001 | 54 | 0.140 |
Why?
|
| Diffusion | 5 | 2012 | 92 | 0.140 |
Why?
|
| Lymphokines | 3 | 2001 | 75 | 0.140 |
Why?
|
| Skin Neoplasms | 1 | 2019 | 510 | 0.140 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2018 | 246 | 0.140 |
Why?
|
| Pilot Projects | 4 | 2007 | 796 | 0.140 |
Why?
|
| Testicular Diseases | 1 | 1994 | 16 | 0.140 |
Why?
|
| Receptors, Mineralocorticoid | 1 | 1994 | 9 | 0.140 |
Why?
|
| Blood Chemical Analysis | 3 | 2004 | 44 | 0.140 |
Why?
|
| Cerebral Angiography | 4 | 1983 | 188 | 0.140 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2010 | 372 | 0.140 |
Why?
|
| Cell Differentiation | 5 | 2006 | 1417 | 0.140 |
Why?
|
| Blotting, Southern | 4 | 1998 | 131 | 0.140 |
Why?
|
| Pulmonary Artery | 3 | 2005 | 283 | 0.140 |
Why?
|
| Lasers | 7 | 1997 | 97 | 0.140 |
Why?
|
| Mitochondria | 5 | 2013 | 518 | 0.140 |
Why?
|
| Medical Oncology | 2 | 2008 | 323 | 0.140 |
Why?
|
| Immunization | 5 | 2000 | 160 | 0.140 |
Why?
|
| Diabetic Nephropathies | 2 | 1997 | 230 | 0.140 |
Why?
|
| Adolescent | 19 | 2004 | 8657 | 0.130 |
Why?
|
| Neoplasms, Experimental | 1 | 1996 | 270 | 0.130 |
Why?
|
| Cochlea | 1 | 1994 | 46 | 0.130 |
Why?
|
| Cell Cycle Checkpoints | 2 | 2013 | 60 | 0.130 |
Why?
|
| Erythema | 3 | 2001 | 27 | 0.130 |
Why?
|
| Quality Control | 3 | 2003 | 112 | 0.130 |
Why?
|
| Adaptation, Physiological | 4 | 2000 | 294 | 0.130 |
Why?
|
| Blotting, Northern | 4 | 2004 | 256 | 0.130 |
Why?
|
| Saccharomyces cerevisiae Proteins | 2 | 1994 | 273 | 0.130 |
Why?
|
| Cytoplasmic Granules | 3 | 2003 | 93 | 0.130 |
Why?
|
| Electrocardiography | 6 | 2001 | 466 | 0.130 |
Why?
|
| Hemodynamics | 3 | 2008 | 677 | 0.130 |
Why?
|
| Biopsy | 4 | 2004 | 1117 | 0.130 |
Why?
|
| Multigene Family | 1 | 1995 | 200 | 0.130 |
Why?
|
| Pheromones | 1 | 1994 | 25 | 0.130 |
Why?
|
| Predictive Value of Tests | 6 | 2011 | 1618 | 0.130 |
Why?
|
| Equipment Design | 3 | 2014 | 400 | 0.130 |
Why?
|
| Radiotherapy Dosage | 3 | 2006 | 480 | 0.130 |
Why?
|
| Bayes Theorem | 2 | 2007 | 329 | 0.130 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 1994 | 46 | 0.130 |
Why?
|
| Melanocytes | 4 | 1998 | 55 | 0.130 |
Why?
|
| Glucose Intolerance | 3 | 2000 | 95 | 0.130 |
Why?
|
| Autoantibodies | 2 | 2006 | 249 | 0.130 |
Why?
|
| Genes, jun | 2 | 2005 | 18 | 0.130 |
Why?
|
| Interferon-alpha | 3 | 2016 | 234 | 0.130 |
Why?
|
| Body Mass Index | 7 | 2001 | 740 | 0.130 |
Why?
|
| Saccharomyces cerevisiae | 2 | 1994 | 427 | 0.130 |
Why?
|
| Cell Degranulation | 2 | 2003 | 15 | 0.130 |
Why?
|
| Glycolysis | 1 | 1994 | 128 | 0.130 |
Why?
|
| Fingers | 1 | 2014 | 65 | 0.130 |
Why?
|
| Photography | 2 | 2012 | 34 | 0.130 |
Why?
|
| Computer Simulation | 8 | 2004 | 1045 | 0.130 |
Why?
|
| Survivors | 1 | 2015 | 201 | 0.130 |
Why?
|
| Mitochondria, Heart | 2 | 1992 | 45 | 0.120 |
Why?
|
| Models, Anatomic | 4 | 1988 | 88 | 0.120 |
Why?
|
| Epithelium | 7 | 2000 | 311 | 0.120 |
Why?
|
| Intestinal Diseases | 1 | 1994 | 77 | 0.120 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2019 | 1156 | 0.120 |
Why?
|
| Retinal Vessels | 1 | 1994 | 54 | 0.120 |
Why?
|
| Spiral Ganglion | 5 | 2001 | 27 | 0.120 |
Why?
|
| Drug Antagonism | 2 | 2003 | 7 | 0.120 |
Why?
|
| Sertoli Cell Tumor | 1 | 2012 | 3 | 0.120 |
Why?
|
| Giant Cells | 2 | 2004 | 18 | 0.120 |
Why?
|
| Blood Vessels | 6 | 1997 | 94 | 0.120 |
Why?
|
| Cyclins | 2 | 2004 | 79 | 0.120 |
Why?
|
| Young Adult | 4 | 2019 | 5701 | 0.120 |
Why?
|
| Intracellular Fluid | 1 | 1993 | 35 | 0.120 |
Why?
|
| Fungal Proteins | 1 | 1994 | 137 | 0.120 |
Why?
|
| Germany | 1 | 2013 | 68 | 0.120 |
Why?
|
| Fertilization | 1 | 1993 | 40 | 0.120 |
Why?
|
| Infusions, Intra-Arterial | 3 | 2001 | 27 | 0.120 |
Why?
|
| Cloning, Molecular | 7 | 2000 | 651 | 0.120 |
Why?
|
| Intubation, Intratracheal | 3 | 2003 | 136 | 0.120 |
Why?
|
| Fasting | 6 | 2008 | 162 | 0.120 |
Why?
|
| Protein Biosynthesis | 4 | 1999 | 369 | 0.120 |
Why?
|
| Extracellular Space | 1 | 1993 | 88 | 0.120 |
Why?
|
| Intracellular Membranes | 1 | 1992 | 116 | 0.120 |
Why?
|
| Vascular Endothelial Growth Factor A | 4 | 2005 | 372 | 0.120 |
Why?
|
| Muscle, Skeletal | 6 | 2002 | 420 | 0.120 |
Why?
|
| DNA-Binding Proteins | 4 | 2013 | 1181 | 0.120 |
Why?
|
| Cytochrome P-450 CYP3A | 2 | 2003 | 42 | 0.120 |
Why?
|
| Polycythemia | 2 | 2004 | 7 | 0.120 |
Why?
|
| Blood | 4 | 1990 | 69 | 0.120 |
Why?
|
| Analysis of Variance | 4 | 2006 | 899 | 0.120 |
Why?
|
| Random Allocation | 4 | 2007 | 334 | 0.120 |
Why?
|
| Adipose Tissue, Brown | 7 | 1998 | 71 | 0.120 |
Why?
|
| Mesenteric Arteries | 2 | 1999 | 28 | 0.120 |
Why?
|
| Heart Rate | 3 | 1992 | 492 | 0.120 |
Why?
|
| Glucagon | 10 | 1983 | 109 | 0.120 |
Why?
|
| Alanine Transaminase | 4 | 2004 | 70 | 0.120 |
Why?
|
| Hyperglycemia | 3 | 2004 | 170 | 0.110 |
Why?
|
| Foreign Bodies | 2 | 2009 | 54 | 0.110 |
Why?
|
| Homeostasis | 4 | 2006 | 387 | 0.110 |
Why?
|
| Bacterial Proteins | 1 | 1998 | 828 | 0.110 |
Why?
|
| Hyperostosis, Cortical, Congenital | 1 | 2011 | 1 | 0.110 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2003 | 139 | 0.110 |
Why?
|
| Ochratoxins | 1 | 2011 | 1 | 0.110 |
Why?
|
| Fumonisins | 1 | 2011 | 1 | 0.110 |
Why?
|
| Blood Pressure | 7 | 2001 | 1141 | 0.110 |
Why?
|
| Gonads | 2 | 2002 | 19 | 0.110 |
Why?
|
| Angiotensin II | 5 | 1999 | 90 | 0.110 |
Why?
|
| Reference Standards | 1 | 2012 | 142 | 0.110 |
Why?
|
| Peptides | 4 | 2002 | 619 | 0.110 |
Why?
|
| Carcinoma, Small Cell | 2 | 2004 | 136 | 0.110 |
Why?
|
| Electrocoagulation | 2 | 2001 | 19 | 0.110 |
Why?
|
| Chick Embryo | 1 | 1992 | 229 | 0.110 |
Why?
|
| Testicular Neoplasms | 1 | 2012 | 97 | 0.110 |
Why?
|
| Glutathione | 4 | 2001 | 102 | 0.110 |
Why?
|
| Cardiomyopathies | 2 | 1991 | 211 | 0.110 |
Why?
|
| Glial Fibrillary Acidic Protein | 3 | 2000 | 59 | 0.110 |
Why?
|
| Regression Analysis | 4 | 2007 | 588 | 0.110 |
Why?
|
| Organotechnetium Compounds | 2 | 2001 | 8 | 0.110 |
Why?
|
| Hemorrhage | 2 | 2005 | 236 | 0.110 |
Why?
|
| Psychophysiology | 1 | 2010 | 9 | 0.110 |
Why?
|
| Albumins | 2 | 2002 | 118 | 0.110 |
Why?
|
| Arteries | 3 | 2002 | 175 | 0.110 |
Why?
|
| Hypoglycemic Agents | 5 | 2007 | 356 | 0.110 |
Why?
|
| DNA, Complementary | 4 | 2002 | 391 | 0.110 |
Why?
|
| Hearing | 5 | 1999 | 55 | 0.110 |
Why?
|
| Observation | 1 | 2010 | 36 | 0.110 |
Why?
|
| Mitochondrial Swelling | 2 | 2004 | 4 | 0.110 |
Why?
|
| Bezafibrate | 2 | 2001 | 5 | 0.110 |
Why?
|
| Treatment Outcome | 7 | 2015 | 7469 | 0.110 |
Why?
|
| Immunity, Mucosal | 2 | 2002 | 67 | 0.110 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2011 | 26 | 0.110 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2002 | 113 | 0.110 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 2 | 2002 | 105 | 0.110 |
Why?
|
| Immunoglobulin M | 3 | 2001 | 154 | 0.110 |
Why?
|
| Confidence Intervals | 3 | 2009 | 223 | 0.100 |
Why?
|
| Survival Rate | 4 | 2002 | 1809 | 0.100 |
Why?
|
| Infusions, Intravenous | 2 | 2002 | 433 | 0.100 |
Why?
|
| Prosthesis Design | 3 | 1996 | 268 | 0.100 |
Why?
|
| Encephalomyelitis | 1 | 2010 | 6 | 0.100 |
Why?
|
| Reagent Kits, Diagnostic | 2 | 1980 | 36 | 0.100 |
Why?
|
| Endolymph | 3 | 1997 | 6 | 0.100 |
Why?
|
| Bile Duct Diseases | 2 | 1987 | 22 | 0.100 |
Why?
|
| Memory | 1 | 1993 | 221 | 0.100 |
Why?
|
| Xenon | 1 | 1990 | 7 | 0.100 |
Why?
|
| Hepatocyte Growth Factor | 2 | 2001 | 82 | 0.100 |
Why?
|
| Synovial Membrane | 3 | 2002 | 27 | 0.100 |
Why?
|
| Calcium Channel Blockers | 3 | 2003 | 225 | 0.100 |
Why?
|
| Tryptophan | 2 | 2001 | 84 | 0.100 |
Why?
|
| Alleles | 3 | 2006 | 1075 | 0.100 |
Why?
|
| Fetal Stem Cells | 1 | 2010 | 2 | 0.100 |
Why?
|
| Calcium Oxalate | 1 | 2011 | 173 | 0.100 |
Why?
|
| Glycosaminoglycans | 1 | 1990 | 47 | 0.100 |
Why?
|
| Disease Reservoirs | 1 | 2010 | 20 | 0.100 |
Why?
|
| Neoplasm Transplantation | 2 | 2005 | 387 | 0.100 |
Why?
|
| Radioimmunoassay | 5 | 1980 | 159 | 0.100 |
Why?
|
| RNA | 2 | 2006 | 505 | 0.100 |
Why?
|
| Inorganic Chemicals | 1 | 2010 | 1 | 0.100 |
Why?
|
| Gallbladder | 3 | 2004 | 26 | 0.100 |
Why?
|
| Elements | 1 | 1990 | 5 | 0.100 |
Why?
|
| Air Pollutants, Occupational | 1 | 1990 | 5 | 0.100 |
Why?
|
| Gene Library | 2 | 2002 | 123 | 0.100 |
Why?
|
| Phenotype | 4 | 1998 | 2246 | 0.100 |
Why?
|
| Fluorine | 1 | 1990 | 17 | 0.100 |
Why?
|
| Hydrofluoric Acid | 1 | 1990 | 6 | 0.100 |
Why?
|
| Phosphorylation | 4 | 2008 | 1094 | 0.100 |
Why?
|
| Autopsy | 1 | 2010 | 98 | 0.100 |
Why?
|
| Coronary Vessels | 5 | 1998 | 180 | 0.100 |
Why?
|
| Diabetic Angiopathies | 2 | 2000 | 63 | 0.100 |
Why?
|
| Thiazoles | 3 | 1999 | 130 | 0.100 |
Why?
|
| Animals, Laboratory | 2 | 2005 | 15 | 0.100 |
Why?
|
| Cytosol | 4 | 2001 | 188 | 0.100 |
Why?
|
| DNA, Neoplasm | 3 | 2000 | 265 | 0.100 |
Why?
|
| Learning | 1 | 1993 | 252 | 0.100 |
Why?
|
| DNA Fingerprinting | 2 | 2007 | 16 | 0.100 |
Why?
|
| Biopsy, Needle | 1 | 2010 | 233 | 0.100 |
Why?
|
| Hypolipidemic Agents | 2 | 2001 | 101 | 0.100 |
Why?
|
| Rats, Transgenic | 1 | 2009 | 3 | 0.100 |
Why?
|
| G2 Phase | 2 | 2010 | 32 | 0.100 |
Why?
|
| Toxicity Tests | 2 | 2000 | 13 | 0.100 |
Why?
|
| Normal Distribution | 2 | 2007 | 38 | 0.100 |
Why?
|
| Cell Separation | 3 | 1995 | 196 | 0.100 |
Why?
|
| Endoplasmic Reticulum | 4 | 1997 | 250 | 0.100 |
Why?
|
| Stria Vascularis | 3 | 1994 | 5 | 0.100 |
Why?
|
| Neuronal Plasticity | 2 | 2003 | 190 | 0.090 |
Why?
|
| Lipoproteins, LDL | 4 | 2004 | 85 | 0.090 |
Why?
|
| Glass | 1 | 2009 | 14 | 0.090 |
Why?
|
| Immunophenotyping | 2 | 2001 | 210 | 0.090 |
Why?
|
| Guanidines | 3 | 1999 | 31 | 0.090 |
Why?
|
| Pneumoconiosis | 2 | 2004 | 3 | 0.090 |
Why?
|
| Pharynx | 1 | 2009 | 39 | 0.090 |
Why?
|
| Aorta, Abdominal | 3 | 1997 | 59 | 0.090 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 2 | 1999 | 17 | 0.090 |
Why?
|
| Brain Ischemia | 1 | 2012 | 311 | 0.090 |
Why?
|
| Keratins | 2 | 2001 | 63 | 0.090 |
Why?
|
| Periodic Acid-Schiff Reaction | 1 | 2008 | 6 | 0.090 |
Why?
|
| Myelography | 1 | 2008 | 11 | 0.090 |
Why?
|
| Osteoblasts | 1 | 2009 | 94 | 0.090 |
Why?
|
| Thiazolidinediones | 2 | 1999 | 81 | 0.090 |
Why?
|
| Periapical Diseases | 1 | 1988 | 2 | 0.090 |
Why?
|
| Verapamil | 2 | 2003 | 76 | 0.090 |
Why?
|
| Neprilysin | 1 | 2008 | 41 | 0.090 |
Why?
|
| Optic Nerve Diseases | 1 | 2008 | 18 | 0.090 |
Why?
|
| Peritonitis | 2 | 1998 | 27 | 0.090 |
Why?
|
| Transcriptome | 1 | 2013 | 512 | 0.090 |
Why?
|
| Kidney Calculi | 1 | 2011 | 313 | 0.090 |
Why?
|
| Feline Acquired Immunodeficiency Syndrome | 2 | 1998 | 2 | 0.090 |
Why?
|
| Mice, Knockout | 4 | 2010 | 1904 | 0.090 |
Why?
|
| Keratosis | 2 | 1999 | 21 | 0.090 |
Why?
|
| Dihydroxyphenylalanine | 2 | 1998 | 13 | 0.090 |
Why?
|
| Cattle | 6 | 2000 | 369 | 0.090 |
Why?
|
| Cell Line, Tumor | 2 | 2005 | 2320 | 0.090 |
Why?
|
| Serine | 2 | 2006 | 98 | 0.090 |
Why?
|
| Microbubbles | 1 | 2008 | 34 | 0.090 |
Why?
|
| Online Systems | 1 | 2008 | 24 | 0.090 |
Why?
|
| Phagocytosis | 2 | 2003 | 80 | 0.090 |
Why?
|
| Chronic Disease | 2 | 2010 | 932 | 0.090 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2010 | 273 | 0.090 |
Why?
|
| Radiography, Panoramic | 1 | 1987 | 7 | 0.090 |
Why?
|
| Aortic Diseases | 4 | 2002 | 99 | 0.090 |
Why?
|
| Nerve Growth Factors | 2 | 1998 | 60 | 0.090 |
Why?
|
| Random Amplified Polymorphic DNA Technique | 1 | 2007 | 6 | 0.090 |
Why?
|
| Lumbar Vertebrae | 3 | 2019 | 149 | 0.090 |
Why?
|
| Signal Processing, Computer-Assisted | 2 | 1990 | 197 | 0.090 |
Why?
|
| Ribotyping | 1 | 2007 | 11 | 0.090 |
Why?
|
| Regeneration | 2 | 2001 | 139 | 0.090 |
Why?
|
| Prions | 2 | 2000 | 51 | 0.090 |
Why?
|
| Viral Load | 2 | 2005 | 136 | 0.080 |
Why?
|
| Cisplatin | 2 | 2001 | 579 | 0.080 |
Why?
|
| Hypotension | 1 | 2008 | 66 | 0.080 |
Why?
|
| Receptors, AMPA | 2 | 2000 | 67 | 0.080 |
Why?
|
| Lipoproteins | 2 | 2000 | 140 | 0.080 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 2 | 1999 | 116 | 0.080 |
Why?
|
| Histones | 2 | 2008 | 293 | 0.080 |
Why?
|
| Placentation | 2 | 2008 | 12 | 0.080 |
Why?
|
| Ethanol | 3 | 2001 | 235 | 0.080 |
Why?
|
| Neutropenia | 1 | 2008 | 210 | 0.080 |
Why?
|
| Antigens, CD20 | 3 | 2005 | 35 | 0.080 |
Why?
|
| Melanins | 2 | 1998 | 22 | 0.080 |
Why?
|
| Decision Making, Computer-Assisted | 2 | 2000 | 12 | 0.080 |
Why?
|
| Cholesteatoma, Middle Ear | 2 | 1999 | 6 | 0.080 |
Why?
|
| Muscle Proteins | 2 | 1999 | 135 | 0.080 |
Why?
|
| Cholesterol, Dietary | 3 | 1995 | 37 | 0.080 |
Why?
|
| Etidronic Acid | 1 | 2006 | 5 | 0.080 |
Why?
|
| Ectodysplasins | 1 | 2006 | 5 | 0.080 |
Why?
|
| Propranolol | 2 | 2005 | 46 | 0.080 |
Why?
|
| Forelimb | 2 | 2011 | 16 | 0.080 |
Why?
|
| Jugular Veins | 2 | 2009 | 70 | 0.080 |
Why?
|
| Inclusion Bodies, Viral | 3 | 2002 | 9 | 0.080 |
Why?
|
| Ileum | 3 | 1997 | 161 | 0.080 |
Why?
|
| Xenobiotics | 1 | 2006 | 6 | 0.080 |
Why?
|
| Hydrogen-Ion Concentration | 4 | 1995 | 494 | 0.080 |
Why?
|
| Microscopy, Confocal | 3 | 2004 | 269 | 0.080 |
Why?
|
| Anaphylaxis | 2 | 2003 | 31 | 0.080 |
Why?
|
| Pancreatic Hormones | 2 | 1983 | 14 | 0.080 |
Why?
|
| Fourier Analysis | 7 | 1995 | 127 | 0.080 |
Why?
|
| Ulcer | 2 | 2004 | 26 | 0.080 |
Why?
|
| Weight Gain | 3 | 1997 | 125 | 0.080 |
Why?
|
| Animal Feed | 2 | 2003 | 22 | 0.080 |
Why?
|
| Aldosterone | 3 | 1994 | 63 | 0.080 |
Why?
|
| Salivary Cystatins | 1 | 2006 | 1 | 0.080 |
Why?
|
| Blindness | 1 | 2006 | 40 | 0.080 |
Why?
|
| Biological Science Disciplines | 1 | 2006 | 12 | 0.080 |
Why?
|
| Cochlear Duct | 3 | 1997 | 4 | 0.080 |
Why?
|
| Cystatins | 1 | 2006 | 5 | 0.080 |
Why?
|
| Transfection | 4 | 2001 | 892 | 0.080 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 3 | 1 | 2006 | 3 | 0.080 |
Why?
|
| Pregnancy in Diabetics | 2 | 1983 | 37 | 0.080 |
Why?
|
| 3',5'-Cyclic-AMP Phosphodiesterases | 1 | 2006 | 8 | 0.080 |
Why?
|
| Desmin | 1 | 2006 | 10 | 0.080 |
Why?
|
| Hypothermia, Induced | 1 | 1987 | 71 | 0.080 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 1 | 2006 | 4 | 0.080 |
Why?
|
| Hypertrophy | 2 | 1997 | 62 | 0.080 |
Why?
|
| Graves Disease | 1 | 2006 | 42 | 0.080 |
Why?
|
| Tissue Distribution | 6 | 2004 | 277 | 0.080 |
Why?
|
| Ventilation-Perfusion Ratio | 1 | 1986 | 13 | 0.080 |
Why?
|
| Transplantation, Heterologous | 2 | 1998 | 352 | 0.080 |
Why?
|
| Muramidase | 1 | 2006 | 35 | 0.080 |
Why?
|
| Genes, cdc | 1 | 2005 | 5 | 0.080 |
Why?
|
| Incidence | 2 | 2003 | 1528 | 0.080 |
Why?
|
| Calcium-Binding Proteins | 1 | 2006 | 111 | 0.080 |
Why?
|
| Pulmonary Gas Exchange | 1 | 1986 | 30 | 0.080 |
Why?
|
| Escherichia coli | 3 | 2002 | 595 | 0.080 |
Why?
|
| Metabolic Detoxication, Phase II | 1 | 2005 | 1 | 0.080 |
Why?
|
| Trachea | 3 | 2005 | 292 | 0.080 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2006 | 42 | 0.080 |
Why?
|
| Potassium Channels | 2 | 1999 | 335 | 0.070 |
Why?
|
| Hindlimb | 2 | 1999 | 86 | 0.070 |
Why?
|
| Herpesviridae | 2 | 1995 | 13 | 0.070 |
Why?
|
| Feline Panleukopenia | 2 | 1976 | 2 | 0.070 |
Why?
|
| Weaning | 1 | 2005 | 24 | 0.070 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2006 | 70 | 0.070 |
Why?
|
| Elasticity | 2 | 1996 | 88 | 0.070 |
Why?
|
| Auditory Perception | 1 | 2006 | 91 | 0.070 |
Why?
|
| Microscopy | 2 | 1998 | 82 | 0.070 |
Why?
|
| Prognosis | 5 | 2000 | 3522 | 0.070 |
Why?
|
| Obesity | 2 | 2007 | 907 | 0.070 |
Why?
|
| Wnt Proteins | 1 | 2006 | 122 | 0.070 |
Why?
|
| Pulmonary Circulation | 1 | 2005 | 84 | 0.070 |
Why?
|
| Tumor Cells, Cultured | 2 | 1998 | 1039 | 0.070 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2006 | 119 | 0.070 |
Why?
|
| Antibody Formation | 2 | 2000 | 170 | 0.070 |
Why?
|
| Glutathione Transferase | 1 | 2005 | 112 | 0.070 |
Why?
|
| Coronary Angiography | 2 | 1999 | 204 | 0.070 |
Why?
|
| Touch | 1 | 2006 | 84 | 0.070 |
Why?
|
| Postoperative Complications | 3 | 2001 | 2067 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2005 | 33 | 0.070 |
Why?
|
| Salivary Ducts | 1 | 2005 | 3 | 0.070 |
Why?
|
| Aquaporin 5 | 1 | 2005 | 2 | 0.070 |
Why?
|
| Pulmonary Veins | 1 | 2005 | 64 | 0.070 |
Why?
|
| Maternal-Fetal Exchange | 2 | 2004 | 75 | 0.070 |
Why?
|
| Sample Size | 1 | 2005 | 120 | 0.070 |
Why?
|
| Gangliosidoses, GM2 | 1 | 2004 | 1 | 0.070 |
Why?
|
| Actins | 2 | 2006 | 429 | 0.070 |
Why?
|
| Spiro Compounds | 1 | 2005 | 25 | 0.070 |
Why?
|
| Free Radicals | 1 | 2005 | 73 | 0.070 |
Why?
|
| Aquaporins | 1 | 2005 | 14 | 0.070 |
Why?
|
| Anthozoa | 1 | 2015 | 13 | 0.070 |
Why?
|
| Inflammation | 4 | 2000 | 819 | 0.070 |
Why?
|
| Inhalation Exposure | 1 | 2005 | 29 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2005 | 68 | 0.070 |
Why?
|
| Gallbladder Neoplasms | 1 | 1985 | 21 | 0.070 |
Why?
|
| Microfilament Proteins | 1 | 2006 | 204 | 0.070 |
Why?
|
| Peripheral Nervous System Neoplasms | 1 | 2004 | 19 | 0.070 |
Why?
|
| S Phase | 1 | 2005 | 61 | 0.070 |
Why?
|
| Fat Emulsions, Intravenous | 1 | 2004 | 11 | 0.070 |
Why?
|
| NF-kappa B | 1 | 2008 | 418 | 0.070 |
Why?
|
| Nose Neoplasms | 1 | 2005 | 31 | 0.070 |
Why?
|
| Parenteral Nutrition, Total | 1 | 2004 | 42 | 0.070 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2006 | 124 | 0.070 |
Why?
|
| Chickens | 2 | 2002 | 217 | 0.070 |
Why?
|
| Neurilemmoma | 1 | 2004 | 32 | 0.070 |
Why?
|
| Cyclin G | 1 | 2004 | 1 | 0.070 |
Why?
|
| Cyclin G1 | 1 | 2004 | 2 | 0.070 |
Why?
|
| Macaca | 1 | 2005 | 88 | 0.070 |
Why?
|
| Graft Survival | 2 | 1999 | 864 | 0.070 |
Why?
|
| Lymphoma, T-Cell | 1 | 2005 | 45 | 0.070 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2005 | 46 | 0.070 |
Why?
|
| Sus scrofa | 1 | 2004 | 44 | 0.070 |
Why?
|
| Mitochondria, Liver | 1 | 2004 | 27 | 0.070 |
Why?
|
| Morphogenesis | 1 | 2006 | 180 | 0.070 |
Why?
|
| Microwaves | 2 | 2001 | 24 | 0.070 |
Why?
|
| Binding Sites | 3 | 1998 | 1083 | 0.070 |
Why?
|
| Milk | 1 | 2004 | 45 | 0.070 |
Why?
|
| beta Catenin | 1 | 2006 | 232 | 0.070 |
Why?
|
| Gallbladder Diseases | 1 | 2004 | 21 | 0.070 |
Why?
|
| Dermatoglyphics | 1 | 2004 | 4 | 0.070 |
Why?
|
| Brain Stem | 3 | 2001 | 157 | 0.070 |
Why?
|
| Heterozygote | 2 | 2004 | 352 | 0.070 |
Why?
|
| Genes, Fungal | 2 | 1994 | 57 | 0.070 |
Why?
|
| Pulmonary Emphysema | 1 | 2004 | 20 | 0.070 |
Why?
|
| Computer Systems | 4 | 1994 | 81 | 0.070 |
Why?
|
| Kinetin | 1 | 2004 | 1 | 0.070 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2004 | 60 | 0.070 |
Why?
|
| Microcirculation | 1 | 2004 | 102 | 0.070 |
Why?
|
| Salivary Gland Diseases | 2 | 1980 | 4 | 0.070 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2004 | 54 | 0.070 |
Why?
|
| Basement Membrane | 2 | 1996 | 55 | 0.070 |
Why?
|
| Cholangitis | 3 | 1990 | 18 | 0.070 |
Why?
|
| Auditory Cortex | 2 | 2006 | 55 | 0.070 |
Why?
|
| Rats, Inbred SHR | 6 | 2000 | 29 | 0.070 |
Why?
|
| Copying Processes | 2 | 1994 | 6 | 0.070 |
Why?
|
| Feline panleukopenia virus | 3 | 1998 | 3 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factors | 3 | 2001 | 56 | 0.070 |
Why?
|
| Central Nervous System Diseases | 1 | 2004 | 47 | 0.070 |
Why?
|
| Neoplasm Metastasis | 2 | 2008 | 1032 | 0.070 |
Why?
|
| Haplorhini | 1 | 2004 | 98 | 0.070 |
Why?
|
| Glucuronosyltransferase | 1 | 2005 | 185 | 0.070 |
Why?
|
| RNA Probes | 1 | 2003 | 16 | 0.070 |
Why?
|
| Transcriptional Activation | 1 | 2005 | 277 | 0.070 |
Why?
|
| Alopecia | 1 | 2004 | 34 | 0.060 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2004 | 109 | 0.060 |
Why?
|
| Mobile Health Units | 1 | 2003 | 11 | 0.060 |
Why?
|
| Chicago | 1 | 2008 | 1327 | 0.060 |
Why?
|
| Centrifugation, Density Gradient | 2 | 2001 | 113 | 0.060 |
Why?
|
| Disinfectants | 1 | 2003 | 9 | 0.060 |
Why?
|
| Longevity | 1 | 2004 | 44 | 0.060 |
Why?
|
| Hot Temperature | 6 | 1987 | 199 | 0.060 |
Why?
|
| Neutrophil Infiltration | 1 | 2003 | 28 | 0.060 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2005 | 158 | 0.060 |
Why?
|
| Isoproterenol | 2 | 1994 | 57 | 0.060 |
Why?
|
| Energy Metabolism | 4 | 2000 | 254 | 0.060 |
Why?
|
| Tunica Intima | 2 | 2002 | 57 | 0.060 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2003 | 35 | 0.060 |
Why?
|
| Mandible | 1 | 2005 | 112 | 0.060 |
Why?
|
| Penaeidae | 1 | 2003 | 1 | 0.060 |
Why?
|
| Aflatoxins | 1 | 2003 | 3 | 0.060 |
Why?
|
| Kidney Medulla | 2 | 1994 | 78 | 0.060 |
Why?
|
| Cyclic GMP | 3 | 1998 | 60 | 0.060 |
Why?
|
| Metals | 1 | 1984 | 88 | 0.060 |
Why?
|
| Thorax | 1 | 2003 | 53 | 0.060 |
Why?
|
| Photofluorography | 2 | 1993 | 2 | 0.060 |
Why?
|
| Dietary Fiber | 2 | 1995 | 42 | 0.060 |
Why?
|
| Probability | 2 | 2004 | 345 | 0.060 |
Why?
|
| Radiology, Interventional | 1 | 2004 | 66 | 0.060 |
Why?
|
| Antiviral Agents | 2 | 1997 | 489 | 0.060 |
Why?
|
| Bronchi | 1 | 2004 | 226 | 0.060 |
Why?
|
| Food Contamination | 1 | 2003 | 30 | 0.060 |
Why?
|
| Chlorpromazine | 1 | 2003 | 15 | 0.060 |
Why?
|
| Ganglioglioma | 1 | 2003 | 4 | 0.060 |
Why?
|
| Aerosols | 1 | 2003 | 43 | 0.060 |
Why?
|
| Amides | 3 | 2000 | 57 | 0.060 |
Why?
|
| Mucous Membrane | 2 | 2001 | 86 | 0.060 |
Why?
|
| Motor Activity | 2 | 2001 | 321 | 0.060 |
Why?
|
| Osteogenesis | 2 | 2009 | 237 | 0.060 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2005 | 441 | 0.060 |
Why?
|
| Gestational Age | 1 | 2004 | 294 | 0.060 |
Why?
|
| Speech Perception | 3 | 1998 | 67 | 0.060 |
Why?
|
| Crystallography, X-Ray | 1 | 2015 | 484 | 0.060 |
Why?
|
| Kanamycin | 3 | 2000 | 10 | 0.060 |
Why?
|
| Ducks | 1 | 2002 | 8 | 0.060 |
Why?
|
| Aflatoxin B1 | 1 | 2002 | 8 | 0.060 |
Why?
|
| Capillary Permeability | 2 | 1996 | 128 | 0.060 |
Why?
|
| Coturnix | 1 | 2002 | 13 | 0.060 |
Why?
|
| Videotape Recording | 1 | 1983 | 48 | 0.060 |
Why?
|
| Severity of Illness Index | 3 | 2004 | 1686 | 0.060 |
Why?
|
| Fusarium | 1 | 2002 | 4 | 0.060 |
Why?
|
| Catheterization | 2 | 2001 | 224 | 0.060 |
Why?
|
| Organ Specificity | 5 | 1999 | 252 | 0.060 |
Why?
|
| Sex Characteristics | 2 | 1997 | 295 | 0.060 |
Why?
|
| Animals, Suckling | 1 | 2002 | 2 | 0.060 |
Why?
|
| Calmodulin | 1 | 2003 | 48 | 0.060 |
Why?
|
| Cholesterol, HDL | 4 | 2001 | 164 | 0.060 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2003 | 131 | 0.060 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2015 | 236 | 0.060 |
Why?
|
| Administration, Inhalation | 1 | 2003 | 180 | 0.060 |
Why?
|
| Heart Ventricles | 2 | 2001 | 724 | 0.060 |
Why?
|
| Vascular Diseases | 2 | 1997 | 112 | 0.060 |
Why?
|
| Cell Line | 5 | 2001 | 2470 | 0.060 |
Why?
|
| Feathers | 1 | 2002 | 12 | 0.060 |
Why?
|
| Restriction Mapping | 3 | 1998 | 158 | 0.060 |
Why?
|
| Ovum | 1 | 2002 | 57 | 0.060 |
Why?
|
| Combined Modality Therapy | 3 | 2001 | 1602 | 0.060 |
Why?
|
| Tarsal Joints | 1 | 2002 | 1 | 0.060 |
Why?
|
| Atrophy | 2 | 1999 | 72 | 0.060 |
Why?
|
| Coronary Circulation | 2 | 2000 | 129 | 0.060 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2002 | 45 | 0.060 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2005 | 288 | 0.060 |
Why?
|
| Thailand | 1 | 2002 | 66 | 0.060 |
Why?
|
| Carcinoma | 1 | 2006 | 412 | 0.060 |
Why?
|
| Dirofilariasis | 1 | 1982 | 2 | 0.060 |
Why?
|
| Polymyxin B | 1 | 2002 | 4 | 0.060 |
Why?
|
| Synovial Fluid | 1 | 2002 | 10 | 0.060 |
Why?
|
| Cardiomegaly | 3 | 1993 | 110 | 0.060 |
Why?
|
| Mycoses | 1 | 2002 | 43 | 0.060 |
Why?
|
| Hybrid Cells | 1 | 2002 | 72 | 0.060 |
Why?
|
| Cloning, Organism | 1 | 2002 | 17 | 0.060 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2002 | 43 | 0.060 |
Why?
|
| Gene Transfer, Horizontal | 1 | 2002 | 33 | 0.060 |
Why?
|
| Fibrinogen | 1 | 2002 | 56 | 0.060 |
Why?
|
| Endothelial Cells | 1 | 2005 | 385 | 0.060 |
Why?
|
| Hematology | 1 | 2002 | 27 | 0.060 |
Why?
|
| Oxygen Consumption | 3 | 2000 | 234 | 0.060 |
Why?
|
| Ankle Joint | 1 | 2002 | 39 | 0.060 |
Why?
|
| Thrombosis | 2 | 2002 | 265 | 0.060 |
Why?
|
| Sternum | 1 | 2001 | 24 | 0.060 |
Why?
|
| Proviruses | 2 | 1998 | 16 | 0.060 |
Why?
|
| Ophthalmoscopy | 2 | 2008 | 9 | 0.060 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2002 | 73 | 0.060 |
Why?
|
| Lead | 2 | 1996 | 22 | 0.060 |
Why?
|
| Pericardium | 1 | 2002 | 68 | 0.060 |
Why?
|
| Mesentery | 1 | 2001 | 46 | 0.060 |
Why?
|
| Simian immunodeficiency virus | 2 | 1999 | 15 | 0.060 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2002 | 98 | 0.060 |
Why?
|
| Neoadjuvant Therapy | 2 | 2000 | 265 | 0.060 |
Why?
|
| Deoxyglucose | 3 | 1999 | 37 | 0.060 |
Why?
|
| Cytochrome P-450 CYP2E1 | 1 | 2001 | 3 | 0.050 |
Why?
|
| Labyrinth Diseases | 2 | 1999 | 4 | 0.050 |
Why?
|
| Ribosomes | 1 | 2002 | 105 | 0.050 |
Why?
|
| Tunica Media | 1 | 2001 | 16 | 0.050 |
Why?
|
| Glutamate-Cysteine Ligase | 1 | 2001 | 7 | 0.050 |
Why?
|
| Pneumocystis | 1 | 2001 | 4 | 0.050 |
Why?
|
| Chi-Square Distribution | 2 | 2009 | 359 | 0.050 |
Why?
|
| Wounds, Penetrating | 1 | 2001 | 43 | 0.050 |
Why?
|
| Thalamus | 1 | 2003 | 124 | 0.050 |
Why?
|
| Thermoluminescent Dosimetry | 1 | 1981 | 5 | 0.050 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2001 | 63 | 0.050 |
Why?
|
| Thyroid Function Tests | 2 | 1980 | 114 | 0.050 |
Why?
|
| rap1 GTP-Binding Proteins | 1 | 2001 | 13 | 0.050 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 2001 | 19 | 0.050 |
Why?
|
| Absorptiometry, Photon | 3 | 2019 | 98 | 0.050 |
Why?
|
| Ventricular Remodeling | 1 | 2002 | 89 | 0.050 |
Why?
|
| Genes, bcl-2 | 1 | 2001 | 17 | 0.050 |
Why?
|
| Hepatic Artery | 1 | 2001 | 76 | 0.050 |
Why?
|
| Sex Factors | 3 | 2007 | 1021 | 0.050 |
Why?
|
| Event-Related Potentials, P300 | 1 | 2001 | 3 | 0.050 |
Why?
|
| Ursidae | 1 | 2001 | 3 | 0.050 |
Why?
|
| Genes, fos | 1 | 2001 | 24 | 0.050 |
Why?
|
| Scapula | 1 | 2001 | 21 | 0.050 |
Why?
|
| Astacoidea | 1 | 2000 | 2 | 0.050 |
Why?
|
| Cyclic GMP-Dependent Protein Kinases | 1 | 2001 | 15 | 0.050 |
Why?
|
| Fetal Death | 1 | 2001 | 59 | 0.050 |
Why?
|
| Antimutagenic Agents | 1 | 2000 | 6 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2001 | 74 | 0.050 |
Why?
|
| Carcinoembryonic Antigen | 1 | 2001 | 35 | 0.050 |
Why?
|
| Dizziness | 1 | 2001 | 18 | 0.050 |
Why?
|
| Body Temperature Regulation | 4 | 1979 | 53 | 0.050 |
Why?
|
| Cobalt | 1 | 2000 | 28 | 0.050 |
Why?
|
| Mice, Inbred C3H | 2 | 2000 | 379 | 0.050 |
Why?
|
| DNA Viruses | 1 | 2000 | 16 | 0.050 |
Why?
|
| Myosin Heavy Chains | 1 | 2001 | 86 | 0.050 |
Why?
|
| Synaptophysin | 1 | 2000 | 10 | 0.050 |
Why?
|
| Hematocrit | 4 | 2004 | 68 | 0.050 |
Why?
|
| Apolipoproteins | 1 | 2000 | 37 | 0.050 |
Why?
|
| Spores, Bacterial | 2 | 1998 | 17 | 0.050 |
Why?
|
| Chemotherapy, Cancer, Regional Perfusion | 1 | 2000 | 8 | 0.050 |
Why?
|
| Mediastinal Neoplasms | 1 | 2001 | 43 | 0.050 |
Why?
|
| Adipocytes | 3 | 1999 | 141 | 0.050 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2001 | 66 | 0.050 |
Why?
|
| Genes, ras | 1 | 2001 | 97 | 0.050 |
Why?
|
| Lipoma | 1 | 2000 | 24 | 0.050 |
Why?
|
| Protein Conformation | 1 | 2004 | 878 | 0.050 |
Why?
|
| Tuberculosis | 1 | 2002 | 96 | 0.050 |
Why?
|
| Contusions | 1 | 2000 | 9 | 0.050 |
Why?
|
| Chromatography, High Pressure Liquid | 4 | 2004 | 303 | 0.050 |
Why?
|
| Dinoprostone | 2 | 1998 | 67 | 0.050 |
Why?
|
| Lipopolysaccharides | 1 | 2002 | 271 | 0.050 |
Why?
|
| Angiography, Digital Subtraction | 2 | 1991 | 84 | 0.050 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2000 | 51 | 0.050 |
Why?
|
| Ear | 1 | 2000 | 18 | 0.050 |
Why?
|
| Tail | 1 | 2000 | 29 | 0.050 |
Why?
|
| Joints | 2 | 1997 | 34 | 0.050 |
Why?
|
| Chromosome Aberrations | 2 | 2000 | 379 | 0.050 |
Why?
|
| Carotid Artery Injuries | 1 | 2000 | 22 | 0.050 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2001 | 84 | 0.050 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2000 | 46 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2011 | 2148 | 0.050 |
Why?
|
| Gravitation | 1 | 2000 | 7 | 0.050 |
Why?
|
| Otolithic Membrane | 1 | 2000 | 6 | 0.050 |
Why?
|
| Oligonucleotide Probes | 1 | 2000 | 42 | 0.050 |
Why?
|
| Molecular Probe Techniques | 1 | 2000 | 9 | 0.050 |
Why?
|
| Ink | 1 | 2019 | 4 | 0.050 |
Why?
|
| Physical Fitness | 1 | 2000 | 44 | 0.050 |
Why?
|
| Genetic Variation | 1 | 2007 | 1314 | 0.050 |
Why?
|
| MAP Kinase Signaling System | 1 | 2001 | 189 | 0.050 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2001 | 176 | 0.050 |
Why?
|
| DNA Nucleotidylexotransferase | 2 | 1996 | 11 | 0.050 |
Why?
|
| Bronchial Spasm | 1 | 1999 | 16 | 0.050 |
Why?
|
| Sialoglycoproteins | 1 | 2000 | 32 | 0.050 |
Why?
|
| Knee Injuries | 1 | 2000 | 50 | 0.050 |
Why?
|
| Fetal Growth Retardation | 1 | 2000 | 70 | 0.050 |
Why?
|
| Leukocytes, Mononuclear | 2 | 1998 | 190 | 0.050 |
Why?
|
| Blood Flow Velocity | 3 | 1991 | 196 | 0.050 |
Why?
|
| Diflucortolone | 1 | 1999 | 1 | 0.050 |
Why?
|
| Cell Membrane | 3 | 2001 | 666 | 0.050 |
Why?
|
| Superoxide Dismutase | 1 | 2001 | 173 | 0.050 |
Why?
|
| Fluocinolone Acetonide | 1 | 1999 | 7 | 0.050 |
Why?
|
| Pregnadienediols | 1 | 1999 | 13 | 0.050 |
Why?
|
| Glycogen | 3 | 2000 | 58 | 0.050 |
Why?
|
| Graft Rejection | 2 | 1997 | 1046 | 0.050 |
Why?
|
| Protoporphyrins | 1 | 1999 | 19 | 0.050 |
Why?
|
| Bone Marrow Cells | 2 | 2000 | 251 | 0.050 |
Why?
|
| Heme Oxygenase-1 | 1 | 1999 | 19 | 0.050 |
Why?
|
| Administration, Cutaneous | 1 | 1999 | 50 | 0.050 |
Why?
|
| Muscle Relaxation | 1 | 1999 | 17 | 0.050 |
Why?
|
| Prednisolone | 1 | 1999 | 42 | 0.050 |
Why?
|
| Ion Channels | 5 | 2000 | 242 | 0.050 |
Why?
|
| Ulna | 1 | 2019 | 12 | 0.050 |
Why?
|
| Epoprostenol | 1 | 1999 | 45 | 0.050 |
Why?
|
| Linear Models | 1 | 2001 | 401 | 0.050 |
Why?
|
| Radius | 1 | 2019 | 27 | 0.050 |
Why?
|
| Adenosine Triphosphatases | 1 | 2000 | 151 | 0.050 |
Why?
|
| Adoptive Transfer | 1 | 2000 | 169 | 0.050 |
Why?
|
| Body Water | 2 | 1996 | 38 | 0.050 |
Why?
|
| Myocardial Contraction | 1 | 2000 | 240 | 0.050 |
Why?
|
| Frameshift Mutation | 1 | 1999 | 52 | 0.050 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 1999 | 65 | 0.050 |
Why?
|
| Peripheral Nerves | 2 | 1999 | 33 | 0.050 |
Why?
|
| Cell Lineage | 1 | 2001 | 282 | 0.050 |
Why?
|
| Lipids | 4 | 1994 | 276 | 0.050 |
Why?
|
| Serine Endopeptidases | 1 | 2000 | 146 | 0.050 |
Why?
|
| Prevalence | 1 | 2003 | 1163 | 0.050 |
Why?
|
| Propofol | 1 | 1999 | 88 | 0.050 |
Why?
|
| Fibrocystic Breast Disease | 1 | 1999 | 12 | 0.050 |
Why?
|
| Diastole | 1 | 1999 | 142 | 0.050 |
Why?
|
| Carbohydrate Sequence | 1 | 1999 | 20 | 0.050 |
Why?
|
| Replication Origin | 1 | 1998 | 5 | 0.050 |
Why?
|
| Fibroadenoma | 1 | 1999 | 9 | 0.050 |
Why?
|